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Malnutrition is associated with an increased
incidence of morbidity and mortality after surgical
operations. The acute phase plasma protein response is
believed to be an important mechanism in the repair and
resolution of inflammation following operation. This study
attempted to determine if the acute phase response is
attenuated by malnutrition and thus a possible contributor
to the observed increase in the incidence of complications
after surgery.
Four groups of patients were studied. Normally
nourished patients with benign disease of the upper
gastrointestinal tract, normally nourished patients with
malignant disease of the oesophagus or stomach,
malnourished patients with malignant disease of the
oesophagus or stomach and malnourished patients with
malignant disease of the oesophagus or stomach who had
received intravenous nutrition for 7 days prior to
operation.
Firstly, nutritional indices of the patients were
assessed. Then, in the in vivo study, the acute phase
proteins C-reactive protein, alpha-]-antitrypsin, and
alpha-]-acid glycoprotein were measured sequentially
following radical surgery for upper gastrointestinal
carcinoma in groups 2, 3 and 4. Finally liver biopsies
from all 4 groups were incubated in vitro in the presence
of interleukin-1 an acute phase stimulant and the
production of C-reactive protein measured using an ELISA
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assay.
The magnitude of the acute phase plasma protein
response in vivo and in vitro was compared amongst the
groups and correlations were sought between the magnitude
of the acute phase plasma protein response in vivo and in
vitro and the various nutritional indices.
No influence of nutritional factors could be
demonstrated in either arm of the study.
This could be a genuine finding or the result of
inadeguacy in the design of the study or the power of the
study in relation to the number of patients studied.
Further studies using methods to improve the
preservation of the liver slices by shorter incubation and
improved oxygenation are suggested.
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1. THE ACUTE PHASE PROTEINS
The acute phase response is a multi-system, non¬
specific response to almost any form of tissue injury
including surgical trauma and bacterial infection,
[Kushner, 1982]. It may be regarded as the systemic
equivalent of the local inflammatory response, the purpose
of which is thought to be to aid tissue repair, resist
further tissue damage and resolve the inflammatory
process. Its manifestations include fever, leukocytosis,
changes in the hormonal milieu and blood coagulability,
increased proteolysis in muscle, and alterations in
gluconeogenesis and lipolysis [Dinarello and Wolf, 1982;
Egdahl et al, 1977; Clowes et al, 1983; Wolfe, 1987;
Wiener et al, 1987]. In addition there are rapid changes
in the plasma concentrations of a number of circulating
proteins, the so called acute phase proteins. These
changes are often in themselves referred to as the acute
phase response but more precisely should be called the
acute phase plasma protein response.
Many of these proteins, e.g. fibrinogen, are normally
present in the plasma and have a physiological role which
is well understood. Others, of which C-reactive protein
(CRP) is the prime example in man, appear in the plasma in
significant concentration only during the acute phase
response and their function remains incompletely
understood. However, there is growing evidence to suggest
that the acute phase proteins act as modifiers of the
inflammatory response, acting as inflammatory mediators,
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enzyme inhibitors, immune regulators and scavengers of
effete macromolecules [Whicher and Dieppe, 1985],
The first step in the acute phase response is the
attraction of mononuclear phagocyte cells to sites of
inflammation. Here contact with micro-organisms, and dead
tissue triggers the release of cytokines which act as the
intermediate messengers for the many facets of the acute
phase response. Thought initially to number only one,
interleukin-1, there are now at least 6 cytokines known to
influence acute phase protein synthesis.
A diagrammatic representation of the pathways of the
acute phase response is given in figure 1, page 12.
The definition of what may be regarded as an acute
phase protein is rather imprecise, since the concentration
of many if not most plasma proteins changes in response to
trauma and sepsis. Kushner proposed a definition based on
a rise of at least 25% in plasma concentration, but
conceded that a definition based on synthesis would be
more satisfactory [Kushner, 1982], since increased
synthesis may be matched by increased consumption thus
masking the acute phase nature of proteins such as alpha2~
macroglobulin, one of the few proteins which in man shows
no change in plasma concentration during the acute phase
response. Others have used the term more widely and even
include proteins whose concentration falls as so called
'negative acute phase' proteins [Lebreton et al, 1979].
If we accept the condition of a rise of at least 25%,











Figure 1. A simplified diagram of the pathway of
initiation of the acute phase plasma protein response
- 12 -
on the relative size of the change in concentration. Some
proteins increase their concentration by several thousand
fold, some by only a few fold, some by a factor less than
one. The principle positive reactants are listed in table
1, page 14 and four of these proteins are discussed
individually below. C-reactive protein is the best known
and longest studied of the acute phase proteins in man and
will be considered in most detail. Serum amyloid A shares
some characteristics with CRP in that it is normally
present in trace amounts but increases its concentration
by a factor of thousands during acute phase stimulation.
Alpha-]-antitrypsin and alpha-]-acid glycoprotein are also
typical acute phase reactants and will be discussed on
account of their role in the experimental section of this
thesis.
C-REACTIVE PROTEIN
C-reactive protein is the archetypal acute phase
protein in man. It is normally present in levels which
until recently were undetectable but following injury or
infection its concentration rises within a few hours to a
level which may be several hundred times higher than
normal. Discovered in 1930 it was the first acute phase
protein to be recognised, but despite being studied for
almost sixty years [McCarty, 1982] its functions are not
known with certainty. Many possible roles have been
suggested and these are discussed below.
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TABLE 1. THE ACUTE PHASE REACTANTS IN MAN.
a) Concentration rises by greater than 10 fold
C reactive protein
serum amyloid A






c) Concentration rises less than 100%
caeruloplasmin
C3






C-reactive protein was discovered by William Tillet
and Thomas Frances working in the laboratory of 0 T Avery
at the Rockefeller Institute in New York [Tillet and
Francis, 1930], who were looking at soluble components of
the pneumococcal cell wall in an attempt to produce a
type-specific antiserum. By repeated freezing, thawing,
acidifying and boiling, they isolated a carbohydrate
moiety from the bacterial cell wall which they called
Fraction C [Tillet et al, 1930], probably because of its
analogy to Lancefield's C substance from the streptococcus
described a few years earlier, also in the Rockefeller
Institute. They added fraction C to sera collected at
frequent intervals from patients suffering from
pneumococcal pneumonia to see if a precipitation reaction
would occur. The observed result was unexpected in that
precipitation was greatest in the samples taken at the
height of the disease whereas samples taken in the
recovery phase produced no precipitate as would have been
expected if this had been a classical antibody/antigen
reaction.
The explanation of this phenomenon and the nature of
the 'C-reactive substance' were made clear only slowly
over the next ten years by further work in the Rockefeller
laboratories under the direction of Avery. Tillet and
Frances had themselves noted the same response in the
serum of patients with endocarditis and other infections
[Tillet and Frances, 1930], and so realised that the
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reaction was not specific to sera from patients infected
with the pneumococcus. They thought that gram positive
cocci were possibly the common link, but it was soon shown
that the reaction occurred with other bacterial infections
including Salmonella typhi and E. coli [Ash, 1933].
Attention then turned to other species and it was found
that serum from infected monkeys also produced the same
precipitation reaction but serum from rabbits and mice did
not [Abernethy, 1937], although these too were later shown
to produce CRP.
Experiments characterising the chemical and
immunological properties of the C-reactive substance were
reported in 1941 [Abernethy and Avery, 1941; MacLeod and
Avery, 1941a; MacLeod and Avery, 1941b] which established
the protein nature of this substance which was now named
"C-reactive protein". It was shown that the C reactive
substance was inactivated by heating above 65°C and
separated with the albumin fraction on ammonium sulphate
precipitation. It was further shown that the precipitation
reaction with the C carbohydrate was abolished in citrated
plasma indicating that the reaction was calcium dependent.
Finally an antibody was raised in rabbits to the C
reactive substance which produced precipitation reactions
at concentrations of C reactive substance of 5 mcg/ml,
considerably lower than that required to precipitate with
C carbohydrate, but still produced no precipitation with
normal sera. It was concluded that the C reactive
substance was a protein which was not present in normal
sera but appeared in response to bacterial infections.
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Structure
Human C-reactive protein consists of five identical
subunits each with a molecular weight of around 21 kD
[Oliveira et al, 1979], arranged into a plate like
structure [Osmand et al, 1977] giving a molecular weight
in plasma of around 110,000 to 144,000 [Gotsleich and
Adelman, 1965], which on crystallising may link to form
decamers. The complete sequence of 187 amino acids has
been determined [Oliveira et al, 1979] and is listed in
appendix 1, page 175. The N-terminal residue is modified
to pyrrolidone carboxylic acid and there is one disulphide
bridge between cysteine residues at positions 36 and 78.
No significant sequence homologies have been found with
any known human protein [Liu et al, 1982], but some
similarities have been noted with the C-gamma-2 site of
human IgG which may be the site of complement activation.
Significant homologies have however been found with both
mammalian and fish CRP, rabbit CRP being more than 90%
homologous [Liu et al, 1982]. The significance of these
homologies is discussed below.
Synthesis and turnover
In man CRP is coded for by a single gene, but in the
rabbit two genes exist and in the plaice three [Goldman et
al, 1987]. Studies in rhesus monkeys have shown that CRP
is synthesised exclusively in the liver [Hurlimann et al,
1965]. Earlier reports of high concentrations of CRP at
sites of inflammation [Kushner and Kaplan, 1961; Kushner
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et al, 1963], which were interpreted as suggesting that
synthesis was occurring locally were refuted by the use of
radiolabel incorporation techniques which identified sites
of synthesis as opposed to sites of concentration.
Three pieces of evidence show that the increased
levels of plasma CRP during the acute phase response are
due to new synthesis rather than release of preformed CRP.
Firstly the finding of low or undetectable levels of CRP
in normal liver by immunohistochemical staining [Kushner
and Feldman, 1978]; secondly, the lag phase from the
initiating stimulus such as surgical operation to the
appearance of increased plasma levels of CRP of around 6
hours consistent with the time required to initiate
protein synthesis [Colley et al, 1983]; Thirdly, rising
plasma levels are associated with increased transcription
of mRNA for several acute phase proteins [Goldberger et
al, 1987].
All hepatocytes can synthesise CRP but synthesis
begins first in periportal cells and spreads by degree to
centrilobular areas, [Kushner and Feldman, 1978] which is
in keeping with the stimulus to production being blood
borne [Macintyre et al, 1982].
The half life of CRP in plasma is about 6 hours in
the rabbit [Chelladurai et al, 1983], and this is not
affected by acute phase stimulation. The fate of CRP lost
from the circulation is not known for certain but would
appear to be consumed principally at the sites of
inflammation where it is known to aggregate.
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Function
Although there have been a number of suggestions for
a useful biological function, the exact role of CRP is not
yet certain. However, two pieces of evidence suggest that
CRP has a fundamentally important function and is neither
an artefact nor an evolutionary remnant of little
biological use. Firstly, there is the proportion of the
protein synthesising capacity of the liver which is
diverted to its production in the face of injury and
infection, times when maximum efficiency of the body's
resources are reguired to ensure survival of the organism.
It has been estimated that up to 40% of all protein
synthesis in the liver may be directed to the production
of acute phase proteins [Whicher and Dieppe, 1985].
Secondly, there is the length of time through which the
structure of this protein has survived the evolutionary
process without significant modification amounting to over
300 million years (see below).
The most widely accepted functions for CRP are
related to the binding affinities which have been
discovered, and the activation of the complement system
which binding induces.
The initial finding of the binding to the C
carbohydrate of the pneumococcus was further investigated
to ascertain which component of this complex molecule was
the actual binding site. The C carbohydrate is a
heteropolymer of N-acetyl-galactosamine, murein, ribitol
phosphate, choline and diaminotrideoxyhexose [Liu and
Gotschlich, 1967; Gotschlich and Liu, 1967; Brundish and
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Baddily, 1968; Tomasz, 1967; Distler et al, 1966], and the
binding site of greatest affinity is with the
phosphorylcholine component [Volanakis and Kaplan, 1971]
which has a Kd of 1.6 x 10~^M. CRP will also bind with
other phosphate monoesters although with lower affinity.
Binding requires the presence of calcium and brings about
the activation of the complement system [Kaplan and
Volanakis, 1974; Volanakis and Kaplan, 1974] by the
classical pathway, activating mechanisms of chemotaxis and
phagocytosis by macrophages. Phosphoryl choline is widely
present in biological lipid membranes and studies with
both natural and artificial lipid bilayer membranes have
shown that they bind CRP [Narkates and Volanakis, 1982]
and that the resulting complement activation renders the
membranes permeable to small molecules [Mold et al, 1981].
More recently there has been described a binding
affinity for components of the nuclear chromatin, sited at
the junction of the polycationic histone protein and the
polyanionic DNA, which has a binding coefficient several
orders of magnitude greater than that for phosphoryl
choline. Binding of CRP to nuclear chromatin also
activates complement thus facilitating dissolution of DNA
[Robey et al, 1984; Robey et al, 1985]. Nuclear chromatin
is one of the most dense and least soluble of
intracellular materials and a specific mechanism for its
disposal from damaged cells at sites of inflammation would
be beneficial to healing and repair.
A possible clinical correlate of this is the
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association in certain connective tissue diseases of an
impaired acute phase protein response and the presence of
circulating antibodies to DNA. It has been speculated that
the failure to clear exposed chromatin at sites of
inflammation is responsible for the appearance of these
antibodies [Robey, 1987].
The role of CRP in opsonising and clearing intact
micro-organisms is not clear, particularly in man. Most
attention has been paid to the pneumococcus, this being
the first noted source of the principle binding ligand,
although binding has also been noted to components of
other micro-organisms including Proteus morganii, some
streptococci and fungi such as Aspergillus sp. [Mold et
al, 1982]. Studies on opsonisation and lysis of
Streptococci in vitro have been conflicting [Hokama et al,
1962; Williams and Quie, 1968; Kindmark, 1971]. Studies of
mice in vivo have shown protection from pneumococcal
infection by loading doses of CRP [Mold et al, 1981;
Nakayama et al, 1983], but no protection was shown against
Salmonella sp. (which do not bind CRP) and interestingly,
partial depletion of complement by the injection of cobra
venom did not remove the protection.
Thus there is evidence for a functional similarity
between CRP and immunoglobulins [James et al, 1983], both
proteins binding to unwanted material and bringing about
the activation of the complement system to effect their
phagocytosis and clearance, but differing in that CRP
recognises molecules that are abnormal 'self' rather than
foreign. Further support for this analogy is provided for
- 21 -
by the finding of amino acid sequence homology between
residues 90-105 of CRP and the C-gamma-2 region of IgG,
which is thought to be the binding site for C1q on the IgG
molecule [Osmand and Short, 1981], although this homology
is thought to be insufficient to suggest a common
evolutionary origin [Liu et al, 1982].
Immune modulation
Initial studies of interactions between CRP and
lymphocytes suggested that this was not a major function
of CRP. Although CRP binds to a proportion of peripheral
blood lymphocytes this did not appear to have significant
influence on proliferation responses, antibody-mediated
cytotoxicity, natural killer cell activity or cytokine
production by lymphocytes [James et al, 1983; Vetter et
al, 1983]. Significant enhancement of cell mediated
cytotoxicity however has been described when lymphocytes
were incubated in the presence of 200 mg/l CRP which is
within the acute phase range in man [Vetter et al, 1986].
More significant perhaps were the effects seen when CRP
was first lysed by treatment with neutrophil derived
proteases. This produced fragments with potent stimulatory
effects on monocyte and neutrophil chemotaxis, superoxide
production and interleukin-1 production by monocytes
[Robey et al, 1987]. This is supported by the location
within these peptides of sequences similar to tuftsin and
its analogues, tetra peptides known to have immuno-
stimulatory activity.
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The stimulation of interleukin-1 production has
stimulated the concept of a 'CRP cycle', a positive
feedback loop maintaining the availability of CRP as it is
consumed at the site of inflammation [Robey and Jones,
1986].
Taken together these finding suggest that CRP
probably acts as a mediator of the immune response at a
local tissue level, but this function is not as clearly
established as its complement activating role.
Phylogenetic aspects
Proteins closely analogous to CRP have been found in
many species in addition to man and the monkey noted
above, including the rabbit [Anderson and McCarty, 1951],
chicken, mouse, horse [Patterson and Mora, 1964], dog
[Dillman and Coles, 1966], guinea pig [Usui, 1964], plaice
[Baldo and Fletcher, 1973] and the horseshoe crab [Robey
and Liu, 1981]. The finding of such a protein in a
primitive invertebrate species indicates genetic
preservation of the molecule for over 300 million years.
As stated above, this feature is one of the strongest
pieces of evidence of the existence of a fundamental
biological role for CRP.
All of these species specific varieties of CRP share
the basic property of calcium dependent binding to C
polysaccharide, have the same basic pentameric structure
(though may form decamers by stacking two subunits) [Baltz
et al, 1983], and have similar amino acid seguences
[Oliveira et al, 1979, 1980; Pepys et al, 1982; de Beer et
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al, 1982],
There are however a number of important differences
in the properties of the various CRP analogues. In some
species, particularly fish, CRP is not an acute phase
protein but is present in the plasma at all times with no
detectable rise under stress conditions [White et al,
1981]. Mouse CRP behaves similarly to human CRP, being
present in trace amounts normally and behaving as an acute
reactant but never exceeding 2 mg/l [Siboo and Kulisek,
1978]. In the rat, CRP is normally present at
concentrations of around 300 mg/l and increases by a
factor of 2-3 under conditions of acute phase stimulation
[de Beer et al, 1982].
Another variable property is the ability to activate
complement which might be thought to be fundamental to its
physiological function if this involves clearance of
effete materials from sites of inflammation. Human CRP
when bound to its specific ligands activates the classical
complement pathway, but this effect is not seen in the
mouse [Baltz et al, 1983] or rat [de Beer et al, 1982].
Thus although well preserved structurally, it is not
clear if the function of CRP in these various species
remains the same or whether different functions have
evolved without major changes of structure.
Normal levels and the response to injury
The availability of more sensitive methods of
measurement using radioimmunoassay in the 1970's showed
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that CRP was in fact present in the plasma of normal
individuals, but at low concentrations. Two studies of
healthy subjects have shown median levels of 580 and 800
mcg/1 [Claus et al, 1976; Shine et al, 1981], with levels
as low as 70 mcg/1.
The effect of injury on the plasma concentration of
CRP has been best studied following elective surgical
operation. The concentration of CRP begins to rise after a
lag phase of about 6 hours, reaches a peak at about 48
hours and then, in the absence of complications falls
gradually to normal over 14 -21 days [Rapport et al, 1957;
Crockson et al, 1966; Werner and Odenthal, 1967; Aronson
et al, 1972: Fischer et al, 1976; Colley et al, 1983].
Peak levels reached depended on the degree of surgical
trauma inflicted, though there is controversy over what
degree of trauma is required to obtain maximal
stimulation. One study [Colley et al, 1983] showed a
greater rise in plasma CRP following herniorrhaphy than
the Trendelenburg operation for varicose veins with peaks
of approximately 110 and 15 mg/l respectively. However,
they found no greater rise in CRP levels with greater
degrees of surgical trauma as represented by
cholecystectomy, hemicolectomy and hip replacement, but
the numbers of these other operations were relatively
small. It was suggested that there existed a maximal rate
of synthesis after uncomplicated surgical procedures that
was stimulated by relatively minor degrees of trauma such
as herniorrhaphy. They did note however a marked spread of
peak values within the apparently homogeneous
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herniorrhaphy group ranging from 38 to 196 mg/1.
This finding of a maximal level of CRP stimulated by
herniorrhaphy is at odds with the findings of another
group [Dominioni et al, 1980] who found a correlation
between peak CRP levels and degree of surgical trauma
extending to more major procedures. However their
procedures other than "excision of melanoma" might all be
regarded as major (subtotal gastrectomy, total gastrectomy
and abdomino-perineal excision of rectum) and the spread
of values for peak CRP after these three procedures was
not wide and not statistically significant, though this
was not stated. Their data could therefore be consistent
with the hypothesis that surgical trauma produces a
maximal peak of CRP following relatively minor procedures.
Clinical applications of the measurement of CRP
The acute phase plasma protein response is found in
nearly all inflammatory states whether infective or non
infective. The presence of CRP in the acute phase of
pneumococcal and other bacterial infections is of
historical significance but a similar rise is seen also in
fungal, parasitic and viral infections, including a modest
rise during the common cold [Whicher et al, 1985], and a
variety of non infective inflammatory states.
From this three clinical applications of CRP
measurement have been identified [Pepys and Baltz, 1983].
Firstly as a screening tool for organic disease, secondly
as a measure of disease activity in infective,
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inflammatory, malignant and necrotic diseases, and thirdly
as a detector of intercurrent infection.
The use of CRP as a screening tool and an indicator
of disease activity is comparable to the use of
traditional indices such as white cell count, erythrocyte
sedimentation rate (ESR) and plasma viscosity and has
found clinical application in a variety of diseases
including rheumatoid arthritis [McConkey et al, 1972],
Crohn's disease [Fagan et al, 1982], and acute
pancreatitis [Mayer et al, 1984]. In rheumatoid disease in
particular CRP levels have been used to monitor not only
disease activity but the effectiveness of treatment
regimes [McConkey et al, 1979].
Serial measurements of CRP postoperatively beyond the
expected peak at 48 hours have shown that a continued rise
or the appearance of a second peak in plasma concentration
is associated with the development of infective
complications [Fischer et al, 1976; Schentag et al, 1984],
and it has been proposed that serial measurements of CRP
might be useful in the early detection of infective
complications, following abdominal and cardiothoracic
surgery particularly in those in whom clinical assessment
is difficult as in the paralysed, ventilated patient in an
intensive care unit. In pancreatitis too, the appearance
of a rising level of CRP after the first phase of the
disease is a sensitive indicator of the development of
complications such as abscess formation and necrosis.
Similarly in conditions not associated with a rise in
CRP levels but where the ESR is raised such as systemic
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lupus erythematosus and scleroderma and leukaemias, the
appearance of a rise in CRP concentration in the plasma
may be the best indicator of intercurrent infection
[Mackie et al, 1979] and monitor of response to treatment
[Schofield et al, 1982].
SERUM AMYLOID A (SAA)
Serum amyloid A shares with CRP the features of very
low normal concentration and a rapid, early rise of many
hundred fold during the acute phase response, but far less
is known about it CRP. It was discovered much more
recently and has been less intensively studied partly on
account of the difficulty measuring it due to its binding
properties.
Structure and synthesis
Serum amyloid A is a non glycosylated protein of
molecular weight 180,000 D [Levin et al, 1973] composed of
subunits of approximately 12,000 D. The amino acid
sequence has been determined [Benditt et al, 1982].
Synthesised in the liver [Pepys and Baltz, 1983], it is
present in plasma almost totally bound to high density
lipoprotein (HDL) as an apoprotein. Present in small
amounts in health the plasma concentration increases by
several thousand fold during acute phase stimulation [de
Beer et al, 1982], from around 1-30 mg/l [Chambers and
Whicher, 1983] to as much as 5 g/l at maximal stimulation
when it may constitute as much as 50% of the protein
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content of HDL [Benditt et al, 1982]. Peak plasma levels
occur within 6-10 hours of the noxious stimulus, earlier
than peak levels of CRP. SAA is one of the components of
amyloid deposited in certain organs in a number of chronic
illnesses, however the relation between persistently
elevated plasma SAA levels and the development of
amyloidosis is not straightforward. Nevertheless, there is
some evidence that those diseases associated with
amyloidosis such as rheumatoid arthritis and Crohn's
disease do produce higher and more prolonged peaks of
plasma SAA concentration [Pepys and Baltz, 1983],
Function
The function of SAA is even less clear than that of
CRP. Because of its association with HDL and in particular
HDL^ a subset of particles rapidly cleared from plasma it
has been proposed [Whicher, 1984] that its function may be
to help clear cholesterol from lipid laden macrophages
emanating from sites of acute and chronic inflammation
with their conseguent cellular destruction.
Clinical use of the measurement of serum amyloid A
The difficulty in measuring plasma SAA due to its
binding to HDL particles has reduced its usefulness as a
marker of the acute phase response when compared to CRP.
Commercial antisera to SAA for immunological assay were
not available as recently as 1984 [Whicher and Dieppe,
1985].
Another factor limiting its usefulness is the extreme
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sensitivity of SAA, which is elevated by stimuli as mild
as the common cold and other minor viral infections
[Whicher et al, 1985; Sarov, 1982]. For these reasons
measurement of SAA has found little use in clinical
practice.
ALPHA1-ANTITRYPSIN (AAT)
AAT is a 45,000 D glycosylated protein with protease
inhibitory activity [Koj, 1974]. Synthesised exclusively
in the liver it has a normal plasma concentration of
approximately 1.6 - 3.4 g/l, which rises to approximately
twice normal after an isolated stimulus such as a surgical
operation, reaching a peak on the third day [Werner and
Odenthal, 1967]. The half life in plasma is 3.9 days
[Kueppers and Fallat, 1969], AAT binds with the neutral
proteases from leukocyte granules namely collagenase and
elastase [Whicher, 1984] in addition to providing
approximately 90% of circulating antitrypsin activity
[Koj, 1974].
Three functions have been proposed for AAT [Whicher,
1984]. Firstly it acts as an inhibitor of excessive
protease activity at sites of inflammation to prevent
activated proteases being released into the general
circulation; secondly, it inhibits proteases acting on the
activation of mediator peptides such as the kallikrein and
complement systems, thus participating in the control
mechanisms of these systems; and thirdly it protects newly
synthesised structural proteins laid down at sites of
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repair [Davies et al, 1982].
There is a specific deficiency syndrome resulting from
the production of two abnormal genetic variants of AAT,
which may be heterozygous or homozygous [Davies, 1974].
The abnormal protein inhibits its own release into the
plasma and AAT laden granules may be seen on histological
examination of the liver of affected individuals. Affected
individuals are liable to pulmonary emphysema and hepatic
cirrhosis, homozygotes usually being affected in early
life.
Alpha-]-antitrypsin has not been adopted as a clinical
tool for use in monitoring the acute phase response on
account of the variable rate of consumption which it
undergoes in chronic vasculitic diseases making plasma
levels inconsistent and not directly related to rates of
synthesis [Whicher and Dieppe, 1985].
ALPIIA1 ACID GLYCOPROTEIN (AAG)
Alpha-1 acid glycoprotein, also known as orosomucoid,
is a heavily glycosylated (carbohydrate content 41%)
protein of molecular weight 45,000 D. The amino acid
sequence is known and the carbohydrate component well
characterised [Arnaud and Gianazza, 1982].
The normal plasma concentration is between 0.5 and
1.4 g/1 which may rise to 3 g/l during acute phase
stimulation [Whicher and Dieppe, 1985], peaking between 72
and 96 hours after initial stimulation such as operation
[Fischer et al, 1976; Colley et al, 1983; Crockson et al,
1966], Its half life in plasma is about 5 days [Weisman et
- 31 -
al, 1961].
In contrast to its structure, the function of AAG is
little understood though certain observations have
prompted suggestions. It has significant seguence homology
with immunoglobulins [Ikenaka, 1972], is expressed on the
surface of some lymphocytes [Gahmberg and Andersson, 1978]
and the purified protein can inhibit T cells [Chiu et al,
1977], implying that AAG may have a role in
immunomodulation.
AAG also promotes fibroblast growth and binds to
newly formed collagen and thus may also have a role in the
repair process after injury [Arnaud and Gianazza, 1982].
Its long half life and slow response time has not
rendered it of use clinically as a monitor of the acute
phase response.
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2. INTERLEUKIN—1 AND THE ACUTE PHASE REACTION
The initiating event in the acute phase response is
the aggregation of macrophages of the mononuclear series
at the site of injury or inflammation and the release of
numerous polypeptide cytokines. The release of these
cytokines is initiated by contact with substances released
from micro-organisms and inflamed and traumatised tissue.
Of the known specific stimulants the most potent is the
lipopolysaccharide known as endotoxin, released from the
cell wall of effete bacteria. The list of released
cytokines known to be active in the acute phase response
has grown considerably in the last few years. As recently
as 1984 it was thought that interleukin-1 was the common
mediator for all the acute phase phenomena and a simple
unified model was proposed [Dinarello, 1984b]. It is now
realised that there are several different mediators
including interleukin-1, interleukin-6 (interferon-beta2,
hepatocyte stimulating factor), interferon-gamma, tumour
necrosis factor-alpha and tumour necrosis factor-beta
(cachexin). Furthermore it is now known that there are
species differences in the various effects of these
cytokines and different spectra of acute phase proteins
are stimulated by each cytokine. The role of interleukin-




Interleukin-1 (IL-1) is the name given to a protein
formerly known by a variety of names, including endogenous
pyrogen (EP), leukocyte endogenous mediator (LEM) and
lymphocyte activating factor (LAF). Steadily accumulating
evidence, reviewed by Dinarello [Dinarello, 1984a], that
these molecules had similar molecular weights, kinetics of
action, iso-electric points and cells of origin culminated
in the proposal at an international meeting of cell
biologists in 1979 [Aarden et al, 1979] that these
proteins were identical. The name interleukin-1 was
coined to emphasise the role of this protein as a
messenger between leukocytes. At the same meeting the name
interleukin-2 was given to a polypeptide formerly known,
amongst other names, as thymocyte mitogenic factor, and
the interleukin family was born. Currently there are six
members.
Structure and synthesis
Interleukin-1 is a 17,000 Dalton peptide with two
distinct subspecies designated IL-1 alpha and IL-1 beta,
the latter being the predominant form in man.
Interleukin-1 (of either form) is synthesised as a
precursor protein with a molecular weight of approximately
33,000 which is cleaved intracellularly removing the N-
terminal end to produce the active form before release
into plasma [Giri et al, 1985]. Further cleavage takes
place in the plasma and the resulting fragments of
approximately 4.3 kD retain biological activity. Cleavage
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to this smaller fragmment may be essential for some
functions, including release of amino acids from skeletal
muscle. For this reason the name "proteolysis inducing
factor" has been given to the 4.3 kD fragment [Clowes et
al, 1983].
The complete amino acid seguences have been
determined (appendix 2), by amino acid analysis of the
purified protein for IL-1 alpha [Cameron et al, 1985] and
by isolation and seguencing of the corresponding DNA for
both IL-1 alpha [Gubler et al, 1986] and IL-1 beta [Auron
et al, 1984]. Both have been cloned by recombinant DNA
techniques. The two forms may be distinguished by their
iso-electric focusing points, the pi of IL-1 alpha being
approximately 5 and that of IL-1 beta 7.
Despite similar biological activity of IL-1 alpha and
beta only four small areas of homogeneity exist designated
A-D [Auron et al, 1985]. Two of these are located in the
precursor fragment, leaving two areas C & D near the
carboxy terminal end which have been proposed as the
active site.
The sequence of murine interleukin has also been
determined [Lomedico et al, 1984] and is considerably
different from the human form with only 62% homogeneity to
IL-1 alpha the pi of which it shares.
Cells of origin
Cells of the mononuclear phagocyte series represent
quantitatively by far the most important source of
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interleukin-1. These cells include circulating monocytes
as well as peritoneal macrophages, pulmonary alveolar
macrophages, hepatic Kupffer cells and splenic
macrophages, and all are capable of producing assayable
guantities of interleukin-1 [Dinarello, 1984a], when
suitably stimulated. This is consistent with the known
role of these cells in inflammatory processes.
However a number of other cells have been
demonstrated to produce interleukin-1, including corneal
epithelium [Grabner et al, 1982], epidermal keratinocytes
[Sauder et al, 1982] and glial cells [Fontana et al,
1982]. The role of interleukin-1 is less clear in these
tissues but it probably acts locally rather than
systemically [Dinarello, 1984b].
Stimulation of production
The list of substances known to cause release of
interleukin-1 from macrophages is extensive [Dinarello,
1984a], but the most potent are bacteria and bacterial
products, in particular the lipopolysaccharide component
of the cell wall of gram negative bacteria known as
endotoxin. Pico gram concentrations of endotoxin are
capable of stimulating interleukin-1 production in vitro
[Dinarello et al, 1984]. Another toxin, the exotoxin from
Staphylococcus aureus implicated in the toxic shock
syndrome, is egually as potent [Ikejima et al, 1984].
Intact bacteria are also strong stimulators of
interleukin-1 production, with as few as 3 bacteria being
required to induce detectable quantities of interleukin-1
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[Butler et al, 1982], Other stimulators of interleukin-1
production are listed in table 2, page 38 (taken from
Dinarello 1984a).
The mechanism of release is not clear although there
is some evidence that binding of the stimulating substance
to the macrophage cell membrane activates the lipo-
oxygenase enzymes responsible for arachidonic acid
synthesis and ultimately prostaglandin formation
[Dinarello et al, 1983]. There is no evidence of stored
intracellular interleukin-1 and release is prevented by
inhibitors of protein synthesis.
Attenuation of the interleukin-1 response to in vitro
stimulation of mononuclear cells has been described in a
number of clinical situations including protein
malnutrition (see section 3). Reduced interleukin-1
production has also been noted in patients with connective
tissue diseases including systemic lupus erythematosus,
systemic sclerosis, rheumatoid arthritis and mixed
connective tissue disease [Pollack et al, 1983; Whicher et
al, 1986]; with solid tumours [Linker-Israeli et al, 1983;
Herman et al, 1984]; and with overwhelming sepsis [Luger
et al, 1986].
The reduced production of IL-1 in connective tissue
diseases is consistent with the known deficiency of acute
phase proteins in these patients and may have clinical
relevance to the appearance of certain auto-antibodies in
the connective tissue diseases (see section 1). The
relationship with malignant disease observed in breast and
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TABLE 2. INDUCERS OF INTERLEUKIN-1 PRODUCTION
Microorganisms
Viruses, bacteria, spirochetes, yeasts
Microbial Products
Endotoxins from gram negative organisms
Peptidoglycans







Antigens (via antibody or lymphokine production)
Microbial antigens (eg. old tuberculin,
staphylococcal proteins)
Non microbial antigens (eg. ovalbumin, penicill
albumin)








Bleomycin, muramyl dipeptide, CRP
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colon cancer and melanoma in the study by Linker-Israeli
was complex, in that production was diminished in both
early and advanced tumours but normal in intermediate
grades of tumours. The finding of a refractory state in
early tumours suggested by the authors is unsubstantiated,
since a similar study by Herman and colleagues [Herman et
al, 1984] found no such effect in early tumours, but
confirmed the attenuating effects of advanced tumours. As
is discussed in section 3, the differentiation of effects
due to advanced malignancy from those due to malnutrition
is often difficult given the frequent association of these
two phenomena. This point was not addressed in either of
these papers.
Luger and colleagues described a failure of
interleukin-1 production in patients who died from severe
sepsis as compared with survivors and normal controls
[Luger et al, 1986]. This mirrored a similar finding with
regard to proteolysis inducing factor reported earlier
[Clowes et al, 1985]. It remains an open question whether
this is a terminal event of end stage multi-organ failure,
or whether the failure of the acute phase reaction
is a significant factor contributing to the deaths or
both, in a 'vicious spiral' of decline.
BIOLOGICAL ACTIONS OF INTERLEUKIN-1
Much of the study of the actions of interleukin-1 has
been carried out in vitro. Until the recent availability
of large quantities of recombinant interleukin-1 the
principal source of interleukin-1 for experimental work
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was from macrophages cultured in the presence of a
suitable stimulant and only limited quantities suitable
for cell culture work could be obtained.
Other strategies employed to study IL-1 have been the
measurement of plasma interleukin-1 activity (by bioassay)
in various clinical states and the reproduction of a
biological effect by the transfer of plasma from one
animal to another.
Acute phase protein production
The earliest reports of the ability of interleukin-1
to stimulate the production of acute phase proteins
appeared in 1971, when reports from two groups both
demonstrated that injection of LEM into rats produced an
elevation of acute phase protein concentrations (Pekarek
et al, 1972; Eddington et al, 1971]. Similar responses
were also subsequently noted in rabbits [Merriman et al,
1975] and mice [Sipe et al, 1979],
Two problems arose in the interpretation of these
observations. Firstly the purity of the stimulating
substance was suspect and secondly it was difficult to
decide if LEM was acting directly or via a second
messenger. The LEM used was a crude extract from
stimulated polymorphonuclear leukocytes (but in reality
arising from contaminating mononuclear cells present in
the same specimen), and probably contained many other
substances. However the correlation of acute phase protein
stimulation with the pyrogenic effect observed when the
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same preparation was injected into abnimals suggested that
it was indeed LEM (or EP) that was the active substance.
The absence of any hormonal influence in this
response was later demonstrated , by repeating the
experiments in endocrine ablated animals [Wannemacher et
al, 1975].
The issue was further resolved by the use of
hepatocyte cultures. Hepatocytes cultured from the rat
[Koj et al, 1985], and mouse [Baumann et al, 1983] were
shown to produce acute phase proteins in response to
exogenous IL-1 prepared from conditioned (stimulated)
monocytes from the same species. In addition rat and mouse
hepatocytes in culture were also stimulated by conditioned
medium from human monocytes [Gauldie et al, 1987], and
keratinocytes [Baumann et al, 1984]. These experiments
eliminated the possibility of a secondary messenger or a
second cell type, but the purity of the interleukin-1
preparations remained a problem, which was only resolved
with the availability of pure interleukin-1 prepared by
genetic engineering.
The availability of recombinant-DNA IL-1 and other
cytokines has revealed new complexities in the mechanisms
of acute phase stimulation which had already been
suspected from work using fractionated preparations of
conditioned monocyte medium, and has revealed that there
are several cytokines capable of stimulating production of
acute phase proteins, that they have differing importance
in different species and that they produce a different
spectrum of proteins in each species. [Kushner, 1987]
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The ability of human IL-1 to induce synthesis of the
complete array of acute phase proteins was brought into
question by studies using human hepatoma lines [Darlington
et al,1986; Baumann et al, 1987] but when tested on murine
cell lines the full spectrum of activity was found
[Ramadori et al, 1985]. Unfortunately it has not yet
proved possible to culture normal human hepatic cells
hence complete elucidation of the controlling mechanisms
of acute phase protein synthesis in man may be some way
off.
Muscle proteolysis
In order to synthesise new protein in the liver a
source of amino acids is required and this may be provided
by the breakdown of skeletal muscle that accompanies
trauma and sepsis. IL-1 was shown to be capable of
inducing proteolysis in skeletal muscle by experiments
involving the incubation of muscle in the presence of IL-1
in vitro [Baracos et al, 1983]. At the same time another
group from Boston demonstrated the same activity in a
peptide isolated from the plasma of patients with trauma
and sepsis [Clowes et al, 1983]. This peptide which they
named 'proteolysis inducing factor' (PIF) had a molecular
weight of 4,300 D as opposed to the 15,000 D of IL-1.
Further work however showed this new peptide to be a
cleavage fragment of IL-1 [Dinarello et al, 1984].
This suggested a consistent mechanism whereby IL-1
not only promoted synthesis of acute phase proteins in the
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liver but also provided the substrate for their synthesis
by the breakdown of skeletal muscle.
Fever
The role of IL-1 in the genesis of fever has been
long established as witnessed by the name endogenous
pyrogen (EP) one of the former names for IL-1 [Atkins and
Wood, 1955]. Regardless of the initiating cause fever is
mediated by the release of IL-1 from macrophages which
then acts on the thermoregulatory centre in the
hypothalamus by a mechanism involving prostaglandins of
the E series [Dinarello and Wolff, 1982]. This last fact
explains the efficacy of cyclooxygenase inhibitors such as
aspirin in reducing body temperature during fever.
Immune modulation
Amongst the former names of IL-1 was lymphocyte
activating factor on account of its role in the
proliferation of both T and B lymphocytes. The activation
of T-cells appears to depend on the direct action of IL-1
on T helper cells to induce the synthesis of IL-2 which is
the major controlling factor in the proliferation of most
T cell subsets [Mizel, 1982].
Less well characterised is the effect on B cell
proliferation. Antibody production is noted to be
enhanced in the presence of IL-1 [Dinarello, 1984b]. Some
of the increase in immunoglobulin synthesis may be direct
[Wood and Cameron, 1976] and some via the indirect action
of IL-2 [Farrar and Koopman, 1979].
- 43 -
Neutrophil release from the bone marrow is also
stimulated by IL-1. The mechanism appears to be a direct
action [Dinarello, 1984a] increasing the peripheral
leukocyte count within 30 minutes of injection of IL-1 in
the rat [Kampschmidt and Upchurch, 1980].
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3. THE EFFECT OF MALNUTRITION AND REFEEDING
IN THE SURGICAL PATIENT
Malnutrition means bad nutrition and may exist in
many forms. As well as the spectre of global protein
energy deprivation familiar in areas of famine it also
includes the effects of overnutrition, with consequent
obesity, and problems associated with imbalances of
nutrition. Imbalances include deficiencies of specific
nutrients such as vitamins and minerals causing particular
deficiency syndromes, and protein deprivation in the
presence of adequate calorie intake which causes
kwashiorkor characterised by a swollen abdomen and
peripheral oedema.
While recognising the importance of these various
forms of malnutrition which may have their own
implications for surgical practice it is with the problem
of global undernutrition that I am principally concerned
and it is to this that I will refer in using the term
'malnutrition'.
In man, as in other animals, deprivation of food
produces metabolic adjustments in order to maintain
essential bodily functions. The most obvious change is
that the body must obtain both energy and substrates for
biosynthesis from stored reserves. Energy is stored in the
form of glycogen in liver and muscle, protein, principally
in skeletal muscle, and fat in adipose tissue. Amino acids
for protein synthesis and essential gluconeogenesis are
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derived principally from the skeletal muscle mass.
Glycogen is present in relatively small amounts in the
liver and skeletal muscle and is therefore strictly
limited to short term utilisation being completely
exhausted within hours.
The most noticeable and early effect of malnutrition
is the wasting of muscle and adipose tissues as these are
broken down and mobilised for utilisation elsewhere. In
order to limit the exhaustion of stored reserves it is
necessary to reduce consumption of energy and substrates.
It is the adoption of a 'siege economy' metabolic state
with reduction in activity and capacity of protective
physiological mechanisms which is the basis for the
harmful effects of malnutrition long before total
exhaustion of supply leads to organ failure and death.
Although the concept of a 'siege economy' is a rather
teleological view of the physiological changes which
accompany malnutrition it helps I think to establish a
concept of subclinical malnutrition which does not depend
on the presence of gross cachexia to be manifest and
indeed may be present in the grossly obese.
In gastrointestinal disease malnutrition arises for a
number of reasons. Food intake may be reduced by anorexia
and nausea which accompanies many gastrointestinal
diseases. Obstructions of the gastrointestinal tract such
as oesophageal stricture and pyloric stenosis may also
prevent food intake and food may be lost by vomiting. Even
when ingested, food may not be adequately digested or
absorbed due to diseases of the pancreas, biliary tree and
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small bowel. Therefore gastrointestinal disease by its
very nature in affecting the organs responsible for intake
and assimilation of food has a high probability of being
accompanied by some degree of malnutrition.
Weight loss and malignancy are commonly associated
but it is not always certain that this weight loss is due
to malnutrition in the sense of inadeguate availability of
nutrients. Despite much investigation the mechanism or
mechanisms remain obscure [Theologides, 1974]. The factors
outlined above certainly play a part but there are
patients in whom weight loss occurs despite adequate food
intake and no measurable deficiency in digestion and
absorption. Attempts at an explanation of this phenomenon
have looked at the metabolic rate of tumour tissue itself,
effects on the host metabolic rate mediated by hormones
and other mediators, and 'futile cycles' in adipose tissue
[Theologides, 1974], No single satisfactory explanation
has however been arrived at.
Any study which defines malnutrition by weight loss
and includes cancer bearing patients must take this into
account since if inadequate intake is not a prime
causation of weight loss then provision of extra food by
whatever means will not have any beneficial effect. In
studies of the therapeutic effect of food provision, the
benefit induced in patients whose weight loss is indeed
due to failure of food supply may be masked by those whose
weight loss is not.
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THE EFFECTS OF MALNUTRITION IN SURGICAL PATIENTS
Almost no physiological process is ultimately immune
from the effects of malnutrition but I will discuss here
firstly those abnormalities that are in common use as
methods of assessment of malnutrition and secondly those
which are likely to have a direct bearing on the frequency
of postoperative complications by diminishing the
mechanisms of repair and resistance to infection.
THE ASSESSMENT OF NUTRITIONAL STATUS
Although it is easy to think of malnutrition in
conceptual terms as outlined above it is much more
difficult to produce a definition which can be applied to
an individual. The assessment of an individual's
'nutritional status' remains one of the most difficult
tasks for the clinician and researcher alike. Many indices
have been proposed as markers of nutritional status but
all have limitations to a greater or lesser degree and
there is no single 'gold standard' to which one may refer.
In surgical practice there is an unfortunate tendency
to make the assumption that because malnutrition is a
cause of post operative complications a good marker of
malnutrition, therefore, is one which has a strong
association with the occurrence of postoperative
complications. This argument has tended to lead to the
acceptance of 'nutritional markers' and 'prognostic
nutritional scores' which may have little true
relationship to nutrition per se but are instead really
markers of illness reflecting many underlying processes.
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Anthropomorphic measurements
Anthropomorphic measurements attempt to estimate the
masses of various components of the body composition by
direct or indirect means. The commonly estimated values
are for body weight, mid arm circumference, skinfold
thicknesses in the biceps, triceps, subscapular, and supra
iliac regions. From the skinfold measurements may be
derived the lean body mass [Durnin and Womersley, 1974]
Less commonly the mass of certain elements such as
potassium, nitrogen and carbon may be determined. From
measurements of total body potassium (which may be
estimated by the counting of emitted radiation from
naturally occurring ^®K), and total body nitrogen (which
may be estimated by the technigue of in vivo neutron
activation analysis [Oxby et al, 1980]), may be derived
the body cell mass and the mass of skeletal muscle
[Burkinshaw et al, 1979].
It is clear that any of these values measured once in
a single individual can only tell whether that individual
is big or small, fat or thin, and unless they lie at the
extreme ends of the ranges of variability carry no
information on the nutritional state of that individual
whatsoever. To be constitutionally thin is not to be
malnourished as is attested by many long distance runners,
but it does imply a reduced level of reserves in the event
of loss of supply of nutrition which may bring an early
impairment in physiological mechanisms.
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Anthropomorphic measurements do however have value
when applied to populations of patients, who may be
assumed to be abnormal if their group values differ from a
matched group of the normal population, and when applied
serially to an individual when the measured variables
change with time.
One exception is provided by the observation that the
ratio of total body potassium to total body nitrogen
(TBK/TBN) does not change with body size in the normal
population [Morgan and Burkinshaw, 1983] but is reduced in
patients with rapid weight loss [Cohn efc al, 1981;
Burkinshaw and Morgan, 1985], probably due to a
disproportionate loss of skeletal muscle. This offers the
possibility of assessing a patient's nutritional status
from a single measurement of elements of body size but
this technique lacks sufficient precision and is
principally a research tool at present.
Estimation of plasma proteins
The estimation of circulating plasma proteins, and in
particular albumin, represents an attractive method of
assessing malnutrition because of the ease of performance
and the apparently simple relationship between substrate
supply and synthesis, and hence circulating levels. Serum
albumin concentration remains the most commonly cited
'nutritional marker' in the surgical literature.
There are however a number of pitfalls in the use of
albumin as a marker of malnutrition.
i) Synthesis of albumin may be reduced by disease states
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which affect liver function despite an adequate substrate
supply as in hepatitis, cirrhosis, and many forms of
malignancy.
ii) In the acute phase response albumin acts as a negative
acute phase reactant. Therefore any condition in which the
acute phase response is activated including the
postoperative state will result in an inhibition of
albumin synthesis.
iii) Plasma albumin concentration may be reduced by excess
losses from the gut and urinary tract.
iv) Loss to the extravascular space occurs in many disease
states due to the leaky capillary syndrome [Jeejeebhoy,
1962].
v) Plasma albumin concentration may be reduced by
dilution. Bed rest alone may be associated with a rise in
plasma volume of 7% with equal reduction in plasma albumin
concentration [Eisenberg, 1963], and many of the disease
states under discussion produce a further increase in
extracellular and plasma volume.
vi) The long half life in plasma (20 days) means that it
responds only slowly to changes in nutritional status
produced by disease or nutritional intervention.
vii) The type of malnutrition may affect the degree to
which plasma albumin is reduced. Protein deprivation in
the face of adequate calorie intake may produce severe
reductions in plasma albumin, but in combined protein and
energy malnutrition depression of plasma albumin is a
later and less marked phenomenon.
It is now quite clear that non nutritional factors
especially the changes in vascular volume and loss to the
extracellular space are far more important determinants of
albumin concentration and that therefore as a method of
assessing nutrition in the surgical patient population,
many of whom will be suffering from malignant and/or
inflammatory processes albumin has limited value.
Other transport proteins such as transferrin and
prealbumin suffer similar disadvantages except that they
have a shorter half life.
Muscle function
The simplest 'function' of skeletal muscle to measure
is its strength. As skeletal muscle wastes, its strength
which varies with cross sectional area falls regardless of
any metabolic changes which take place at a cellular
level. A convenient group of muscles to measure in this
way are the forearm muscles responsible for grip strength
which can be measured with a simple dynamometer calibrated
in kilograms force. However this method suffers from the
disadvantage that grip strength varies with many factors
other than nutrition, including age, sex, occupation and
the presence of intrinsic disease of the hand and forearm
and so, like anthropomorphic data, a single measurement
can only say whether an individual is strong or weak
though the malnourished as a group are likely to be weaker
than average. In addition there is a considerable day to
day variation in measured values to up to 30% [personal
data]. For all these reasons an individual reading must be
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interpreted with caution.
An alternative approach is to measure characteristics
of muscle contractility which are dependent on energy
supply rather than muscle bulk. A method has been
described for measuring the response of the adductor
pollicis muscle to an electrical stimulus applied to the
ulnar wrist at the nerve [Edwards et al, 1977]. This
muscle was chosen for ease of recording after it had been
shown to behave in a similar fashion to other larger
muscle groups. The variables measured are the maximum
relaxation rate (MRR) and the force frequency relationship
(FFR). The force frequency measurement compares the force
generated at a stimulation frequency of 20Hz to that at
100Hz. As the relaxation rate decreases, the closer the
two figures become. Because it is dependent on metabolic
changes which can occur before any visible wasting is
noted this technique has been advocated as a sensitive
index of subclinical malnutrition [Russell et al, 1983].
Jeejeebhoy has demonstrated that patients with
gastrointestinal disease who were malnourished as assessed
by recent weight loss and clinical assessment have
significantly different values for both MRR and FFR to a
matched group of normally nourished patients and these
parameters had a significant negative correlation with the
degree of weight lost [Lopes et al, 1982]. Nutritional
repletion by intravenous feeding was shown to return
muscle function towards normal in this study and also in
patients with anorexia nervosa [Russell et al, 1983].
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Immunological function
Epidemiological studies in third world countries have
repeatedly shown a relationship between protein energy
malnutrition and the incidence of a number of infectious
diseases [Tomkins, 1986], but the mechanisms of this
association remain poorly understood, and there is a great
deal of conflicting evidence in the literature. Most
workers have not shown any difference in circulating
antibody levels between normal and malnourished
individuals [Keet and Thorn 1969; Najjar et al, 1969], and
tests of cell mediated immunity in vitro have been shown
not to be related to protein energy malnutrition in
hospital patients [Dowd et al, 1986]. The use of delayed
cutaneous hypersensitivity to test antigens has aroused a
great deal of controversy. Several investigators have
claimed that anergy to test antigens results from protein
energy malnutrition and is restored by intravenous
nutrition [Meakins et al, 1977; Kaminski et al, 1985].
However delayed cutaneous hypersensitivity is affected by
the presence of malignancy and infection which many of the
malnourished patients have suffered from and unravelling
these is complex [Meakins et al, 1977]. Indeed in a major
review of the subject [Twomey et al, 1982] it was
concluded that there was no hard evidence to associate
skin anergy to malnutrition because of the failure of the
experimental designs to take into account other factors
which influence the reaction.
That malnutrition is associated with increased
liability to infection in the community and in hospital
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patients seems clear from epidemiological data, but the
mechanisms for this remain obscure and the use of
immunological tests currently available as tests of
malnutrition or predictors of postoperative outcome is
unproven.
Wound healing
An association between nutrition and wound healing
has been recognised for at least 70 years [Clark, 1919].
Most observers have concentrated on either the association
between hypoproteinaemia and the incidence of wound
disruption [Rhoades J E, et al, 1942; Efron, 1965] or the
effect of specific nutritional deficiencies, particularly
vitamin C and zinc, on wound healing either in patients or
experimental animals [Hunt, 1941]. For reasons outlined
above neither of these may be appropriate indicators of
malnutrition in patients. A recent series of experiments
measuring "wound healing response" by the deposition of
hydroxyproline in an implanted porous tube has suggested
that even minor degrees of malnutrition are associated
with impaired wound healing response and that this can be
reversed by adeguate food intake either by the oral or
intravenous routes without the need to fully restore body
reserves or return plasma protein values to normal
[Haydock and Hill, 1986; Haydock and Hill, 1987; Windsor
et al, 1988].
The importance of wound healing in the genesis of
morbidity and mortality lies not only in the healing of
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the external wound but particularly in the healing of
intestinal anastomoses, whose disruption is invariably
associated with serious consequences.
MALNUTRITION AND THE ACUTE PHASE RESPONSE
No study in man has looked directly at the effect of
nutrition on the production of acute phase proteins in
response to a stimulus such as an operation [Dionigi et
al, 1983]. Nutrition has been studied in relation to the
acute phase response in three areas; firstly the effect of
nutrition on 'background' levels of acute phase proteins;
secondly the effect in animals of protein deprivation on
acute phase protein synthesis; and thirdly the effect of
malnutrition on the ability of stimulated monocytes to
produce interleukin-1 in both man and animals.
A study of the effect of seven days of preoperative
intravenous nutrition in 20 patients with predominantly
malignant gastrointestinal conditions [Coombes et al,
1986] showed no statistically significant difference in
the pre-operative plasma concentration of C-reactive
protein. They noted however that those patients who did
experience a rise in CRP also showed a reduction in the
plasma concentration of other plasma proteins more usually
accepted as markers of nutritional status including
thyroxine binding prealbumin, transferrin and retinol
binding protein suggesting that the rise in plasma CRP
concentration was not related to any improvement in
nutritional status but to an activation of the acute phase
response. It also correspondingly suggested that a fall in
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the carrier protein concentrations may also have been due
to factors other than the nutritional intervention by
intravenous feeding. The use of background levels, that is
the plasma concentration in an individual who is not
subject to an overt source of stimulus of the acute phase
response, is unsuitable as a means of determining the
degree to which the acute phase response is modulated by
nutritional status since it is much more sensitive to
stimulation by subclinical infections and minor trauma
than by the relatively small contribution of nutrition. It
is therefore necessary to assess the acute phase response
to a consistent or supramaximal stimulation in order to
observe the influence of nutrition.
Animal work
It has been demonstrated that protein starved
experimental rats have an impaired ability to produce
acute phase proteins. Rats fed on a protein free but
otherwise normal diet for eighteen days produced lower
plasma levels of acute phase globulins in response to
injury (the implantation of a fixed volume of foreign
material) than normally fed rats [Neuhaus et al, 1963].
Similarly, isolated perfused livers from rats fed protein
deficient diets for six days released less alpha-1 acid
glycoprotein than livers from normally fed rats [Miller
and John, 1970].
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Nutrition and interleukin-1 production
The effect of nutritional status on interleukin-1
production has been examined in both animal models and
human studies.
Work done on the rabbit [Hoffman-Goetz and Kluger,
1979] showed that the febrile response to inoculation with
a pathogenic gram negative bacterium was attenuated in
protein deprived animals. However when the animals were
injected with endogenous pyrogen (EP) raised from
leukocytes of healthy donor animals, the control and
protein deprived animals mounted a similar febrile
response. From this it was concluded that the attenuation
of the fever was caused by failure of synthesis of EP
rather than an inability to react to it in an appropriate
manner. A similar later study carried out in rats
[Bradley et al, 1987] found the converse, namely that
dietary protein deprivation did produce an attenuated
febrile response to an injection of purified interleukin-1
as well as to injections of endotoxin.
Follow up studies were carried out in rabbits
[Hoffman-Goetz et al, 1981] by the injection of EP raised
from the leukocytes of malnourished patients before and
after 7 days of intravenous nutrition. Patients were
divided into those with protein energy malnutrition
(marasmus) and those with predominantly protein
deprivation (kwashiorkor). The degree of fever produced
increased after nutritional repletion, that in the
kwashiorkor group from the lowest level. When a similar
protocol was employed in rats [Keenan et al, 1982] the
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results were less clear cut but the ability of the
patients' macrophages to produce leukocyte endogenous
mediator in vitro as assayed by the leukocyte response
following injection into the rat was also related to
dietary protein intake. These studies suggest that the
rabbit and the rat may behave differently or the
differences in the experimental methods may account for
the slightly differing findings in the two animals.
Attenuation of the capacity of monocytes to produce
interleukin was also found in a study of malnourished
children in India [Bhaskaram and Sivakumar, 1986].
Macrophages from children with severe kwashiorkor or
marasmus and controls were stimulated in vitro to produce
interleukin-1 which was then assayed in a conventional
thymocyte assay. Interleukin-1 production from the cells
of malnourished children was significantly less than
controls.
It is therefore clear that the production of acute
phase proteins may be reduced in man through malnutrition
either by the reduced production of the mediator
interleukin-1 or by the reduced capacity of the liver to
synthesise acute phase proteins in response to
interleukin-1 and other cytokines. The evidence cited
above supports the effect of malnutrition on the first
part of this chain but an effect on the second part has
not yet been demonstrated.
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THE RELEVANCE OF MALNUTRITION
Malnutrition concerns surgeons because they believe
that the physiological effects of malnutrition outlined
above may compromise the patient's ability to recover both
from the disease process and the trauma of a surgical
operation and its complications, and because some degree
of malnutrition is common amongst surgical patients for
reasons which have been discussed above.
THE FREQUENCY OF MALNUTRITION IN THE SURGICAL POPULATION
The frequency with which malnutrition is recognised
to occur in a general surgical practice depends on the
methods used to assess it. In a survey carried out in a
single day on all the surgical patients in a single
hospital in the USA [Bistrian et al, 1974], it was
estimated that up to 67% of patients were malnourished.
Albumin, triceps skinfold thickness and mid arm muscle
circumference were determined. Moderate malnutrition was
defined as albumin < 35 g/1, or anthropomorphic
measurements less than 90% of expected, and severe
malnutrition as albumin < 28 g/1 or anthropomorphic
measurements < 60% of predicted, the normal values being
taken from World Health Organisation statistics for the
sample population [Jelliffe, 1966]. The proportions in
each group were respectively: albumin - 27% moderate, 27%
severe; triceps skinfold thickness - 21% moderate, 35%
severe; mid arm muscle circumference - 36% moderate, 12%
severe.
A similar British study carried out in Leeds [Hill et
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al, 1977] surveyed the entire surgical population of a
large teaching hospital. Using the criteria of weight
loss, arm muscle circumference, plasma albumin, plasma
transferrin, haemoglobin and red blood cell vitamin levels
they found malnutrition in between 20 and 55% of patients.
The greatest incidence of malnutrition was found in
patients who were in hospital more than one week after
major surgery whose assessment would have been affected by
the effects of surgery and sepsis. However in the group of
patients measured before surgery between 13 and 39% still
had evidence of malnutrition by these criteria.
EFFECTS OF MALNUTRITION ON POSTOPERATIVE COMPLICATIONS
As long ago as 1930 it was noted that patients with a
significant degree of weight loss had a higher risk of
complication following operation for chronic peptic ulcer
[Studley, 1930]. More than 20% weight loss was associated
with a 10 fold increase in risk of death, from 1 of 28
patients (3.5%) to 6 of 18 patients (33.3%). Since then
many other indices of malnutrition have been shown to be
associated with an increased risk of postoperative
complications.
The next to be studied was the plasma protein level
[Rhoads and Alexander, 1955]. A rise in infectious
complications from 16.7% to 61.8% was found in patients
with a total protein level of less than
63 g/1 in a sample of over 100 patients. Albumin alone has
also freguently been used as a marker for malnutrition in
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assessment of surgical risk [Forse and Shizgal, 1980;
Leite et al, 1987], both alone and in conjunction with
other nutritional markers in scoring systems, the best
known of which is the Prognostic Nutritional Index of
Buzby and Mullen [Buzby et al, 1980], incorporating plasma
albumin, plasma transferrin, triceps skinfold thickness
and a score for cutaneous delayed hypersensitivity. The
Prognostic Nutritional Index was shown to have a strong
correlation with freguency of complications in a
prospective study of 100 patients [Buzby et al, 1980].
Despite the limitations of grip strength as an
indicator of malnutrition, it has been claimed that grip
strength alone is a sensitive predictor of the risk of
postoperative complications [Klidjian et al, 1982]. This
group found that grip strength below 85% of expected
identified 90% of patients suffering significant
postoperative complications in a group of 120 undergoing
gastrointestinal surgery. This was remarkable since the
normal value used was based on sex alone [Klidjian et al,
1980], with no consideration of age, which has been shown
to have a significant influence on grip strength, and
other groups have not been able to achieve a similar
result.
Thus malnutrition as measured by various criteria has
been repeatedly shown to be associated with an increased




If malnutrition is a significant contributor to
morbidity after surgery then it would appear logical that
nutritional support in the preoperative period should
reduce the incidence of complications and this should be
demonstrable by properly designed clinical trials. In
practise this has proved very difficult despite many
attempts and no trial to date has shown convincing
evidence of significant benefit derived from the
administration of preoperative nutritional support.
This may be a true finding, namely that no benefit is
conferred by preoperative nutritional support, which would
suggest that the abnormal findings of weight loss, low
plasma protein concentrations, poor muscle function etc
are produced principally by the disease process and only
in a minority or to a minor degree by a deficiency of
nutrient supply. Assessment of the efficacy of
preoperative nutritional repletion should therefore
examine whether the physiological abnormalities attributed
to malnutrition can be reversed as well as the clinical
outcome following surgery improved and this has already
been achieved for most of the systems studied.
Alternatively the lack of observed efficacy of
preoperative nutrition may be due to inadeguacies in the
designs of the trials as has been suggested [Silberman,
1985]. Shortcomings in design have included inadeguate
length of preoperative feeding [Holter and Fischer, 1977],
inadeguate numbers of patients [Thompson et al, 1981],
failure to make malnutrition an entry criterion to the
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study [Heatly et al, 1977], and failure to randomise
[Starker et al, 1986]. The most impressive results have
come in a study from Philadelphia in the USA [Mullen et
al, 1980]. In a group of 154 patients undergoing a major
intrathoracic or intra-abdominal resection, the provision
of preoperative intravenous nutrition to a high risk group
(defined as Prognostic Nutritional Index greater than 50%)
reduced postoperative major septic complications 6 fold
and mortality 5 fold. This degree of benefit has not been
reproduced elsewhere. The selection of patients for
feeding was made on undefined clinical grounds and the
implication must be that this has introduced a major
degree of bias to the results.
Even the trial credited with the best design [Muller
et al, 1982], failed to admit patients on the basis of
evidence of malnutrition. Nevertheless in 125 patients,
undergoing gastrointestinal resection, randomised to
intravenous feeding and control groups, the provision of
10 days of preoperative intravenous nutrition produced a
reduction in major complications from 19 to 11% and
mortality from 11 to 3%, both significant at the 5% level.
No difference was seen in the incidence of wound
infections or pneumonia.
Against a background of generally negative results
these relatively modest benefits have failed to bring
about the widespread use of preoperative nutritional
support for patients with weight loss or other indications
of malnutrition. Definitive answers to the questions of
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whether preoperative nutritional support is beneficial, to
whom it should be given, in what form and for how long it
should be given are clearly urgently needed, but the
difficulties of mounting a properly designed trial of
adeguate size have proved insurmountable to date.
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4. AIMS OF THE STUDY
The aim of this study was to investigate a possible
relationship between the nutritional status of patients
undergoing major gastrointestinal surgery and their
ability to mount an acute phase response. As has been set
out in the introduction patients who are malnourished have
an increased risk of post operative complication and
death, and the acute phase response appears to be a
mechanism important in the recovery from injury and
infection. It has been conjectured that malnutrition may
impair the acute phase response and thereby (as one factor
amongst many) prejudice the patient's recovery.
The relationship was to be studied in two ways.
Firstly (the in vivo study) acute phase plasma proteins
would be measured in the early postoperative phase in
groups of patients with and without clinical evidence of
malnutrition undergoing major surgery, and the influence
of nutritional markers on the rise in concentration was
looked for.
Since the magnitude of the acute phase response is
determined by strong influences other than nutrition (the
magnitude of the surgical trauma, the presence of
infection etc) it was anticipated that detecting an
influence of nutrition in vivo might be difficult.
Therefore secondly, in the in vitro study I set out
to devise a model for the study of the acute phase
response in vitro which could be used to study the acute
phase response of liver under controlled conditions. This
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involved the incubation of human liver in the presence of
an acute phase stimulant, when only pre-existing patient
factors and not factors relating to the operation
undergone by the patient would influence the response.
This model would then be used to measure synthesis of an
acute phase protein (C-reactive protein) under conditions






The patients used in these studies were those of the
Professorial Surgical Unit of the General Infirmary at
Leeds. Four groups of patients were studied;
i) a control group of normally nourished individuals
undergoing elective surgery for cholelithiasis or peptic
ulcer disease (group 1)
ii) patients undergoing surgery for gastro-oesophageal
carcinoma who had lost less than 7.5% of body weight
(group 2)
iii) patients as for group ii who had lost more than 7.5%
of body weight (group 3)
iv) patients as for group iii who had received seven days
of intravenous nutrition prior to operation (group 4).
Data was collected from all subjects to quantify the
degree of malnutrition and to assess liver function
preoperatively. In the cancer patients data was also
collected to quantify the tumour load and the degree of




4. Weight loss (%)
Weight loss was calculated as the difference between
measured weight and either the previously measured weight
where this was available or the patient's recall weight
three months before admission. 7.5% represents
approximately 1 stone in the average man.
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5. Height (cm)
6. Triceps skinfold thickness (mm)
This was measured over the triceps at a point in the arm
mid way between the greater tuberosity of the humerus and
the olecranon using skinfold callipers (Holtain Ltd,
Crymmych, UK).
7. Mid arm circumference (mm)
This was measured at the same point as 6 above.
8. Plasma albumin (g/l)
9. Plasma alkaline phosphatase (IU/1)
10. Plasma aspartate amino transferase (IU/1)
11. Plasma bilirubin (mmol/l)
Items 8-11 were measured by the routine hospital
biochemistry service on a seguential multiple analysis
computer (1SMAC1).
Patients in groups 2,3 and 4 had the following
information recorded in addition.
12. Site of tumour, classified as follows;
1 middle third oesophagus
2 lower third oesophagus
3 cardia




13. Stage of tumour, classified as follows;
1 confined to mucosa
2 not penetrating wall
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3 penetrating wall
4 lymph nodes involved
5 distant metastases
14. Operation performed
15. Duration of operation (minutes). This was taken from
the anaesthetic record.
16. Complications which occurred prior to discharge from
hospital and were detected by the medical staff attending
the patients during routine care. No special
investigations were carried out to detect complications
specifically for the purpose of this study. The
complications were defined as follows;
1. Wound infection: The discharge of pus, or of
serous fluid with a positive bacteriological culture.
a) minor; not delaying discharge or recovery
b) major; delaying discharge or recovery
2. Deep abscess: Operative finding, the discharge of
pus from an intra-abdominal or intrathoracic site or
ultrasound or computed tomography evidence of a deep
collection in association with fever greater than 38.5°C
and/or white cell count greater than 15 x 10^/1.
3. Wound dehiscence: the dehiscence of the deep
layers whether or not the skin dehisces.
a) minor; not requiring resuture
b) major; requiring resuture.
4. Chest infection: purulent sputum in association
with clinical or radiological signs of pulmonary collapse
or consolidation.
5. Septicaemia: Positive blood culture in association
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with appropriate clinical signs.
6. Anastomotic leak:
a) radiological
b) clinical; operative or post mortem finding or the
presence of a fistula or the presence of a deep abscess or
peritonitis in association with a radiological leak.
7. High segment deep venous thrombosis: thrombosis in
the ileo-femoral segment confirmed by venography.
8. Pulmonary embolus: diagnosed by
ventilation/perfusion isotope scanning or pulmonary
angiography.
INTRAVENOUS NUTRITION
The solution administered consisted of 1600
kilocalories as glucose (Glucose/electrolyte solution,
Boots, Nottingham, UK), 12.5 g of nitrogen as a balanced
solution of amino acids (Freamine, Boots, Nottingham, UK),
vitamins (Multibionta, Merck, Alton, UK), and minerals.
Fat was added as Intralipid 10% solution on the first and
last days of the course (Kabi-Vitrum, Uxbridge, UK) only
in sufficient guantity to provide essential fatty acids.
Intravenous nutrition was delivered via a tunnelled
silicone elastomer subclavian central venous catheter
(Nutricath, Vygon, Ecouen France) placed specifically for
the purpose and used exclusively for intravenous
nutrition.
The nutrient solutions were compounded in the
aseptic suite of the pharmacy, and were delivered as a
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continuous 24 hour infusion using an controlling pump to
regulate the rate of flow.
Intravenous nutrition was stopped on the evening of
the day before operation and was not recommenced after
operation unless a complication occurred, such as an
anastomotic leak, which would delay the return to eating
or the commencement of enteral nutrition.
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2. THE IN VIVO STUDY
In this arm of the study blood samples were collected
in the post-operative period in order to measure the
concentrations of acute phase proteins. The levels
measured in the different patient groups were then
compared and correlations sought between acute phase
protein concentrations and patient nutritional variables.
Patients from groups 2, 3 and 4 as defined on page 69
were entered into this arm of the project, ie. those
undergoing gastric or oesophageal resection for carcinoma.
Blood was collected at the following times; 7 days
and 1 day preoperatively, at the beginning of the
operation, and at 12, 24, 36, 48 and 72 hours post
operatively. Ten mis of blood was placed in a lithium
heparin tube and centrifuged immediately to obtain plasma
which was stored at -70°C until assay in batches. The






The assays were carried out on an automated
immunoassay system [Beckman, Los Angeles, USA] using the
principle of laser nephelometry. A measured aliquot of
plasma was added to a solution containing excess antibody
to the substance to be measured. A laser beam was passed
through the liquid and caused to scatter by the resulting
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antigen/antibody complexes in solution. The degree of
scatter was measured by a photoelectric cell placed at an
angle to the direction of travel of the laser beam. The
concentration of the test substance was derived by
comparison to standard curves obtained by measurements of
samples of known concentration.
C-reactive protein was measured at all the time
intervals indicated. For the other proteins the 12 and 36
hour samples were omitted because the plasma
concentrations of these proteins react more slowly.
All 34 patients had blood samples taken at 0, 24, 48
and 72 hours and 21 had samples taken at both 12 and 36
hours. This was less than the whole study population as it
was felt unjustified to wake patients in the night to take
blood samples from those who did not have indwelling
vascular access. All of these samples were analysed for
CRP. The decision to measure the other four proteins was
taken after the beginning of the study and before
duplicate specimens were kept. The first four patients
(study numbers 1,3,5,7) therefore did not have
measurements of these proteins, leaving 30 samples for
analysis split 17, 8 and 5 into groups 2, 3 and 4
respectively.
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3. THE IN VITRO STUDY
In this arm of the study patients in all four groups
as defined on page 69 were investigated. Liver was taken
by biopsy at the time of operation, cut into thin slices
and incubated at 37°C for variable periods and under
varying conditions of atmosphere and incubating mechanism.
CRP was measured in the medium and in the liver samples at
the end of incubation and the synthesis of CRP was
compared amongst the four groups and correlations were
sought with nutritional variables.
This part of the study was conducted in two phases as
the conditions of incubation initially chosen were unable
to sustain the liver slices for the duration of the
experiment. This had a deleterious effect on the ability
to draw conclusions from the experiment.
Liver biopsy
From each subject a wedge biopsy of the left lobe of
the liver weighing between 0.24 and 2.16 g was obtained at
laparotomy, by a standard surgical technique [McGinn,
1981], immediately after the abdomen was opened. The
sample was placed directly into a sterile solution of 0.9%
saline stored at 4°C and transported on ice to the
laboratory, where it arrived within 5 minutes of removal.
Sample processing
The gross sample was placed on a sterile filter paper
on the platter of an electronic balance (Electrobalance,
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Cahn Instruments, Cerritos, California, USA.) and the
weight noted.
Using sterile instruments, the sample of liver was
first trimmed with a scalpel to remove the liver capsule
and then cut into strips approximately 0.5x1 cm in
section removing visible areas of connective tissue as
much as possible. The liver specimens were then placed
onto a soft grade filter paper to which they adhered and
the filter paper was attached by clips to the platter of a
Mcllwain tissue slicer (Mickle Laboratory Engineering Co,
Guildford, UK) with one or two drops of water to help the
paper lie flat on the platter. This device [Mcllwain and
Buddie, 1953] consisted of a slicing arm onto which was
mounted a standard double edged razor blade (Wilkinson
Sword Ltd, Cramlington, UK) which was made to rise and
drop by spring tension onto a platter which was
mechanically synchronised to advance by a variable
increment in time with the chopping action of the arm. The
size of the increment was adjusted by a micrometer and was
set to 0.4 mm after experimentation to achieve the
thinnest slices which would slice consistently.
Following sectioning the specimen was returned to the
iced saline where the slices were teased apart with a fine
spatula and a scalpel ready for transfer to the tissue
culture dishes.
One to four slices weighing in total between 4 and 73
mg were then transferred to a sterile single use tissue
culture dish (Lux 5221, Miles Laboratories Inc.,
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Naperville, Illinois, USA) and covered with 5 ml of
medium. These were then covered with a lid sitting on lugs
which allowed the circulation of gas. The dishes were then
placed in an incubator.
The medium
The basic medium chosen was Dulbecco1s modified
Eagles medium (DMEM; for composition see appendix 3). To
this was added in a proportion of 1 part to nine parts of
medium, either foetal calf serum (FCS) or distilled water.
This was done in order to assess the effect of FCS on the
preservation of the hepatocytes during incubation (both
solutions Gibco Ltd, Paisley, UK). To this was then added
varying amounts of recombinant interleukin-1 alpha
solution containing 1 U/mcl (Cystron, New Jersey, USA) to
give a final concentration of between 1 and 20 U/ml of
IL-1, in order to construct a dose response curve. The
majority of incubations were carried out in the presence
of 10 U/ml IL-1. Antibiotics were also added (see below).
All solutions were mixed aseptically in beakers
cleaned in detergent solution, rinsed seguentially in tap
water, absolute alcohol and doubly distilled water, before
autoclaving at 130°C. Sterile graduated syringes were used
to draw up the solutions.
Over a magnetic stirrer and using a magnet cleaned by
the same method as the beakers a pH probe was inserted and
the pH adjusted to 7.4 by adding 1 M NaOH drop by drop.
The tonicity of the medium including foetal calf
serum was 309 mosm/kg.
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Incubation
For the first phase of the incubations, the samples
were placed in a laboratory incubator (Laboratory
Electrical and Engineering Co., Nottingham, UK) at 37°C in
an atmosphere of 5% C02 and 95% air and 100% humidity for
a variable period of between 12 and 96 hours.
For the second phase of the incubations the
oxygenation of the samples was increased by suspending the
liver slices at the gas liquid interface and changing the
gas phase to 95% 02/5% C02 as described by Trowell for the
technique of organ culture for less demanding tissues
[Trowell, 1959]. This was achieved by placing the slices
on a raft of stainless steel mesh (Minimesh 940MM:
Expanded Metal Company Ltd, Hartlepool, UK). A strip 2 by
3 cm was bent at the ends to create legs which would raise
the 'platform' to the surface of the liquid with 5ml of
medium in the dish. The culture dishes were then placed on
a perspex carrier specially designed to fit into a
Mcintosh Fieldes anaerobic jar into which it was placed.
This jar is made of cast aluminium with a gas tight lid
and has two gas ports passing through the lid one passing
via a pipe to the bottom of the jar and one opening
directly to the top of the jar. Fifty ml of distilled
water was placed in the bottom of the jar to ensure 100%
humidity when the jar was sealed.
A mixture of 95% 02/ 5% C02 (British Oxygen Co. Ltd.,
London, UK) was passed through the Mcintosh Fieldes jar
for ten minutes at a flow rate of 5 1/min by connecting
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the gas cylinder to the port of the gas jar which opened
at the bottom of the jar and venting the other to the
atmosphere. The duration of gassing was determined by
measuring the oxygen content of the outflow gas using an
oxygen analyser (Model 5552 with sensor, model 5555,
Hudson Corporation, Temecula, California, USA). The
outflow gas reached a steady state within 7 minutes at an
oxygen concentration indistinguishable from that of the
inflow gas (Figure 2, page 81). A further 3 minutes was
allowed as a safety margin for any pockets of slowly
mixing gas within the jar.
The jar was then placed in the incubator described
above at 37°C.
Weighing of the slices
This was performed after incubation in order to
reduce the risk of bacterial contamination, to reduce
trauma to the unincubated slices and to minimise the
processing time that the liver specimen would spend in in
a cold dry atmosphere. The liver slices were blotted dry
on filter paper and then weighed to the nearest 0.1 mg on
an electronic balance (Electrobalance, Cahn Instruments,
Cerritos, California, USA.)
Preparation of samples for intracellular CRP measurement
Slices for intracellular CRP measurement were
transferred from the balance to a ground glass tissue
homogeniser to which was added 0.5 ml sodium citrate
solution. Citrate was added to prevent CRP binding
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Time (minutes)
Figure 2. Equilibration of the gas mixture in the Mcintosh
Fieldes jar at a flow rate of 5 1/min.
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excessively to damaged cellular components which might
have rendered it 'hidden' to the antibody of the ELISA.
After grinding for two minutes the residue was washed out
of the homogeniser and diluted to 5 ml with DMEM.
Bacterial contamination
Before each incubation a sample of each component of
the medium was sent for quantitative bacterial culture in
the routine diagnostic laboratories in the department of
microbiology. A 1ml sample of the medium from each dish
was also sent after incubation. No antibiotics were added
to the medium initially but the results of the cultures in
the first two incubations showed almost uniform
contamination of the medium by bacteria reported as "mixed
environmental organisms" and it was therefore decided to
add antibiotics to the incubation medium. These were
benzyl penicillin 60 mcg/ml (Glaxo Laboratories Ltd,
Greenford, UK) and gentamicin 50 mcg/ml (David Bull Ltd,
Warwick, UK). These concentrations were taken from
previous work with monolayer hepatocyte cultures and were
known not to be toxic to hepatocytes in culture [Koj et
al, 1984]. The results of the contaminated incubations
were discarded.
Assay of C-reactive protein
After incubation 1 ml of the medium from each
incubation dish was collected and stored frozen at -70°C
before analysis in batches in the department of chemical
pathology using an enzyme linked immunosorbent assay
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(ELISA).
Fifty microlitre aliquots of whole rabbit antisera to
human CRP (DAKO A073) diluted 1:3650 were bound in excess
to a 96 well microtitre plate by overnight incubation (16
hr) in barbitone buffer pH 8.8 at 4°C. The plates were
washed 3 times in phosphate buffered saline, pH 7.2,
containing 0.05% Tween-20 (PBS-T). Samples of the medium
to be measured were then added along with CRP standards in
duplicate 50 mcl aliquots which bound to the rabbit
antibodies following incubation for 2 hr at 37°C. The
standards were diluted in PBS-T containing 10% foetal calf
serum, inactivated by heating to 56°C for 30 min (PBS-T-
FCS). After washing in PBS-T, 50 mcl aliquots of a second
antisera to CRP conjugated to peroxidase were added (DAKO
P227), at a dilution of 1:500 and incubated for a further
t
2 hr at 37°C. This bound quantitatively to the CRP
present. The plates were washed twice with PBS-T and once
with phosphate /citrate buffer pH 5.0. As a substrate for
the enzyme, 100 mcl of a solution containing 34 mg o-
phenylinediamine and 50 mcl hydrogen peroxide in 100 ml
phosphate/citrate buffer, was then added and allowed to
react in the dark for 30 min at 37°C. The reaction was
stopped by the addition of 50 mcl of 2 M sulphuric acid.
Absorbance at 490 nm was then read in a microelisa
minireader, zeroed on control wells containing
phenylenediamine only. A calibration curve was drawn from
LXnca. <!>f
the absorb/ the wells containing the CRP standards and by
comparison a concentration in mcg/1 was obtained. This was
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converted to mcg/mg liver by the following formula;
CRP concentration in medium (mcg/1) x 0.005
weight of slice (mg)
Assessment of cell viability
Assessment of the viability of the liver cells after
incubation was attempted by three methods; firstly
staining with a vital dye, trypan blue, secondly
histological assessment by light microscopy and thirdly by
determination of intracellular enzyme levels before and
after incubation.
i) Trypan blue staining
This was carried out after incubation folowing
trypsin digestion of the slices to obtain single cells
from the liver sample. One of the slices from each dish to
be tested was washed in a buffered salt solution and then
placed in further buffered salt solution containing 10%
v/v trypsin solution (2.5%) and this was agitated at 37°C
for 30 minutes or until the piece of liver tissue had
begun to disintegrate. The solution was then centrifuged
for 5 minutes at 1500 rpm and the cells transferred by
pipette to a measured microscopic grid for counting of
intact and damaged cells.
ii) Histology
After incubation the liver slices were placed in 10%
neutral buffered formalin. The fixed tissue was then
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prepared for histological examination. The liver was
dehydrated by washing with increasing concentrations of
ethanol, 'cleared' by washing in xylol, and embedded in
paraffin wax. After slicing on a microtome the specimen
was dewaxed with xylol and rehydrated with decreasing
concentrations of ethanol. The stains employed were
haematoxylin and eosin (H & E) for routine examination and
periodic acid-Schiff's (PAS) reagent to stain for
glycogen. The stained slices were then mounted and
examined by an experienced gastrointestinal pathologist
who reported on the degree of preservation of the cellular
architecture.
iii) Determination of enzyme activity
Three key enzymes in the glycolytic pathway were
assayed before and after incubation in 10 liver samples.
The enzymes measured were phosphofructokinase, fructose
1,6-diphosphatase and hexokinase. Their position in the
glycolytic pathway is shown in appendix 4, page 179. The
assays were performed as follows.
Phosphofructokinase (PFK).
Weighed samples of chopped liver were homogenised
manually at 0°C in ground glass homogenisers of 100mcl
capacity in a 10 fold dilution of a medium containing
triethanolamine (50 mmol/l), magnesium chloride (2
mmol/1), ethylenediaminetetracetic acid (EDTA) (1 mmol/l),
dithiothreitol (2 mmol/l), and glycerol (2 mol/l),
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adjusted to pH 7.4 with potassium hydroxide. Homogenates
were stored on ice and assayed within 60 min. 1mcl of
homogenate was added to the reacting medium consisting of
Tris/HCl buffer (75 mmol/l) containing magnesium chloride
(7 mmol/l), potassium chloride (100 mmol/l), potassium
cyanide (1 mmol/l), reduced nicotinamide adenine
dinucleotide (NADH) (0.17 mmol/l), adenosine monophosphate
(AMP) (2 mmol/l), adenosine triphosphate (ATP) (1 mmol/l),
fructose 6-phosphate (1 mmol/l), aldolase (0.64 unit),
triose phosphate isomerase (14.3 units), and
glyceraldehyde 3-phosphate dehydrogenase (0.5 unit). The
oxidation of NADH was measured in samples and control
standards without fructose 6-phosphate in a Pye Unicam SP
1800 dual beam spectrophotometer set at 340 nm (Pye,
London, UK).
Fructose 1,6-diphosphatase
Ten mcl of tissue homogenate as prepared above was
added to a reacting medium consisting of Tris/HCl buffer
(50 mmol/l) containing dithiothreitol (2 mmol/l),
magnesium sulphate (6 mmol/l), EDTA (1 mmol/l),
nicotinamide adenine dinucleotide phosphate (NADP+) (0.2
mmol/l), fructose 1,6-biphosphate (1 mmol/l), creatine
phosphate (17.2 mmol/l), creatine kinase (12.5 units),
myokinase (50 units), glucose 6-phosphate dehydrogenase
(0.3 unit), and phosphoglucose isomerase (0.7 unit). The




Ten mcl of tissue homogenate as prepared above was
added to a reacting medium consisting of Tris/HCl buffer
(75 mmol/1) containing dithiothreitol (2 mmol/1),
magnesium chloride (7.5 mmol/1), EDTA (8 mmol/1),
potassium chloride (1.5 mmol/1), NADP+ (0.4 mmol/1), ATP
(2.5 mmol/1), creatine phosphate (10 mmol/1), glucose (1
mmol/1), creatine kinase (12.5 units) and glucose 6-
phosphate dehydrogenase (3 units). The reduction of NADP+
was followed at 340 nm against controls from which glucose
had been omitted. All reagents were obtained from Sigma
Chemical Co, Poole, UK, Boehringer Corporation, London, UK
and British Drug Houses, Poole, UK.
Enzyme activities are given as micromols of product
formed per minute per gram of wet liver.
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4. STATISTICAL METHODS
All data was stored and analysed using the database
software package dBase III+ (Ashton Tate Corporation,
Temecula, USA) on IBM PC compatible microcomputers.
Statistical tests were performed using Oxstat, a
statistical software package (Oxford Logic, Oxford, UK) on
the same machines.
All data was assumed to be non parametric.
Distributions were described by median and interguartile
range (Q1-Q3). The following tests of statistical
significance were employed in the analysis. Correlation
was assessed by Spearman's rank order correlation
coefficient for non parametric data [Siegel, 1956], Groups
of paired data were compared with the Wilcoxon matched
pairs signed ranks test [Wilcoxon, 1945]. The
corresponding test for unpaired data was the Mann-Whitney
U test [Mann and Whitney, 1947],
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5. ETHICAL CONSIDERATIONS
The protocol of this study conforms to the standards
of the Declaration of Helsinki [World Medical Association,
1964]. Ethical permission for the study was obtained from
the Ethical Committee of the General Infirmary at Leeds.
Informed consent was obtained from each patient
undergoing liver biopsy after reading the following
statement;
"We are interested in studying the effect of poor
nutrition on the way in which liver cells help to fight
infection. We would like permission to take some blood
samples from you after your operation (this should not
require any extra needles) and to take a biopsy of your
liver at the time of your operation. Although not entirely
without risk, we believe this is very small and it will
not affect you in any other way nor delay your recovery.




1. DETAILS OF THE PATIENTS
Fifty eight patients were recruited into the study in
total, 34 into the in vivo study and 40 into the in vitro
study (including 14 in both). These were divided into 19
patients with benign disease and no weight loss as
controls for the in vitro study (group 1), 18 patients
with upper gastrointestinal tumours without weight loss
(group 2), fourteen patients with upper gastrointestinal
tumours and weight loss of at least 7.5% of recall body
weight (group 3) and 7 patients as for group 3 who had
received 7 days of intravenous nutrition in the immediate
preoperative period (group 4). Details of the patients are
given in tables 3-6, pages 92 - 95 which lists age,
weight, % weight loss, height, mid arm circumference,
triceps skinfold thickness and plasma albumin.
Each patients was allocated a unique study number (up
to 62, 4 patients having been withdrawn and the number not
reused) regardless of which arm(s) they were entered into.
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Table 3. Details of patients in the in vivo study from group 1.
indicates participation in the in vivo trial, indicates
participation in the in vitro trial
Study no Age Weight Height MAC TSF Albumin
y kg cm mm mm g/1
#2 53 63 158 265 5.4 37
#4 56 68 165 220 5.4 48
#6 27 57 158 250 11.2 43
#9 53 74 169 272 14.0 46
§ 10 42 65 164 244 16.2 40
# 13 50 80 168 284 18.0 45
# 17 43 91 161 335 33.5 41
# 30 42 62 151 210 7.0 40
# 37 57 72 157 290 13.5 42
# 38 35 44 153 208 7.2 41
# 39 26 50 154 227 9.4 40
# 40 49 54 166 246 12.0 48
# 41 38 89 176 292 10.8 46
# 42 57 62 168 285 16.4 43
# 43 76 87 176 312 11.2 42
# 45 73 66 165 257 9.6 37
# 54 47 61 157 283 16.1 47
# 56 55 58 168 260 6.0 44
# 62 18 72 170 260 6.2 44
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Table 4. Details of patients in the study from group 2. indicates
participation in the in vivo trial, indicates participation in
the in vitro trial
Study no Age Weight Height MAC TSF Albumin
y kg cm mm mm g/i
★ 8 69 83 175 215 5.4 37
15 42 89 160 333 17.0 42
★ 18 61 70 163 284 17.0 32
* 19 68 75 171 276 8.6 42
k 21 60 38 153 194 6.6 45
:k 22 53 83 170 292 17.8 43
k 24 70 45 168 221 4.6 36
#* 25 71 76 174 256 9.6 42
H* 27 57 63 170 271 5.6 46
# 31 79 78 160 292 13.4 42
k 33 77 52 168 224 5.6 44
#* 34 78 71 172 273 9.8 34
#* 44 73 68 164 274 6.4 42
* 48 74 47 155 187 3.6 35
* 49 58 49 161 233 11.6 44
#* 51 50 45 161 220 9.2 45
H* 53 70 73 180 274 11.2 41
H* 59 61 69 172 305 9.8 44
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Table 5. Details of patients in the study in group 3. indicates
participation in the in vivo trial, indicates participation in
the in vitro trial.
Study no Age Weight Wt loss Height MAC TSF Albumin
y kg % cm mm mm g/i
★ 3 49 56 11 152 260 21 .4 44
#* 5 71 41 11 155 177 3.0 3
* 7 62 73 11 169 222 3.2 39
# 11 75 62 9 174 72 2.6 36
# 14 58 48 10 147 241 12.0 39
* 20 67 53 9 175 212 3.4 48
# 28 67 72 11 169 298 12.0 44
* 35 72 60 11 158 258 10.6 39
* 36 74 66 10 178 254 8.0 41
* 47 63 56 11 170 205 3.1 34
#* 50 35 65 13 168 277 15.0 44
* 52 58 67 15 164 251 6.4 36
#* 55 73 64 14 168 257 10.6 35
#* 60 82 49 25 170 204 1.9 31
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Table 6. Details of patients in the study in group 4. indicates
participation in the in vivo trial, indicates participation in
the in vitro trial
Study no Age Weight Wt loss Height MAC TSF Albumin
y kg % cm mm mm g/i
#* 1 77 43 10 160 229 8.2 36
#* 12 75 55 18 160 264 5.4 34
* 16 79 57 15 166 251 4.6 38
★ 26 70 56 12 161 274 8.8 37
#* 29 74 65 12 150 308 20.2 33
#* 46 69 52 10 168 209 3.2 44
#* 58 67 42 19 157 214 9.2 40
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2. THE IN VIVO STUDY
Thirty four patients were entered into this arm of
the study; 17 with less than 7.5% body weight loss (group
2), 11 with greater than 7.5% body weight loss randomised
not to receive preoperative intravenous nutrition (group
3) and 6 with greater than 7.5% body weight loss
randomised to receive 7 days of preoperative intravenous
nutrition (group 4).
Details of the patients who took part in this arm of
the study are given in the tables 4 - 6 on pages 93 - 95.
The patients in the in vivo study are marked 1*'.
The results presented here are analysed firstly to
establish that we have observed a typical acute phase
response in the patients studied and secondly to look for
evidence of the influence of the preoperative nutritional
status of the subjects.
Nutritional influence was sought by two methods,
firstly by correlating nutritional variables measured in
the patients with levels of acute phase proteins post
operatively and secondly by comparison of acute phase
protein levels between the 3 groups.
The correlations were performed excluding subjects in
group 4 who had received intravenous nutrition since it
was felt they may have developed a greater postoperative
acute phase reaction than their nutritional assessment
would suggest under the influence of nutritional support
and this might have introduced distortion.
- 96 -
THE ACUTE PHASE RESPONSE
1. Validation of a normal acute phase reaction.
Figures 3-7, pages 98 - 102, show the time course
of the acute phase response for each of the five proteins
measured, C-reactive protein, alpha-]-antitrypsin, alpha-] -
acid glycoprotein, prealbumin and transferrin.
The graphs show that each of these proteins exhibited
a typical acute phase reaction, the three conventional
acute phase proteins rising and the two transport proteins
falling in concentration in response to the trauma of
operation. The highest CRP concentration measured was at
48 hours. The highest concentrations of AAT and AAG were
measured at 72 hours, and the lowest concentrations of
prealbumin and transferrin were seen at 72 hours. Peak and
trough levels are therefore taken as the 72 hour value
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Figure 3. The time course of plasma C-reactive protein













Figure 4. The time course of plasma alpha^-antitrypsin













0 24 48 72
Time (hours)
Figure 5. The time course of plasma alphas-acid
glycoprotein concentration (median, Q1-Q3) following
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Figure 6. The time course of plasma prealbumin












0 24 48 72
Time (hours)
Figure 7. The time course of plasma transferrin
concentration (median, Q1-Q3) following operation in all
the patients studied.
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2. Correlation of protein levels with preoperative
nutritional indices
Correlations were performed between the following
variables.
X axis;
Age (years), height (kg), weight loss (%), height (cm),
mid arm circumference (mm), triceps skinfold thickness
(mm), plasma albumin (g/1), duration of operation (min)
and pathological stage of disease (for key see page 68).
Y axis;
Plasma CRP at 12, 24, 48 and 72 hours.
Plasma AAT at 24, 48, 72 hours
Plasma AAG at 24, 48, 72 hours
Plasma prealbumin at 24, 48, 72 hours
Plasma transferrin at 24, 48, 72 hours
The results of these correlations are given in tables
7-9, pages 104 - 106.
Only 11 statistically significant correlations were
found in 144 performed, 8 at the 0.05 level and 3 at the
0.01 level. Of these 5 were correlations with the duration
of operation. There was no pattern in the other
significant correlations noted which are likely to have
arisen by chance.
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Table 7. Correlations of patient
concentrations of CRP. Values in
order correlation coefficient.
★ ick
0.05 > p > 0.01 p < 0.01.
CRP 12 = CRP concentration at 12
CRP 12 CRP 24
variables with postoperative
the table are R, the Spearman rank
hours etc.
CRP 48 CRP 72
Age -0.08 -0.31 -0.28 -0.17
Weight -0.07 0.30 0.32 0.42*
Wt loss 0.09 -0.02 -0.14 -0.02
Height -0.27 0.17 0.12 0.28
MAC -0.16 0.33 0.33 0.27
TSF -0.30 0.11 0.20 0.25
Albumin -0.12 0.12 0.15 -0.01
Duration op. 0.37 0.02 0.25 0.42*
Tumour stage -0.11 -0.18 -0.40* -0.22
- 104 -
Table 8. Correlations of patient variables with postoperative
concentrations of alpha., -antitrypsin and alpha,-acid glycoprotein.
Values in the table are R the Spearman rank order correlation
coefficient.
0.05 > p > 0.01 p < 0.01.
AAT 24 AAT 48 AAT 7 2 AAG 24 AAG 48 AAG 72
Age -0..20 -0..38 -0.
, **
.65 0,.12 0 .03 0. 18
Weight -0,.04 0..08 0..29 -0..18 -0 .28 -0. 08
Wt loss 0..14 0,. 11 0..09 0,.23 0 .22 0. 13
Height -0..09 0..04 -0..20 0..14 0 .00 -0. 12
MAC 0..03 0..20 0..48* -0,.19 -0 .24 -0. 04
TSF -0,.01 0..17 0..56** -0..27 -0 .29 -0. 07
Albumin -0..05 0..06 0..16 -0,.21 -0 .21 -0. 32
Duration -0..48* -0..26 0..18 -0,.44* -0 **.53 -0. 42*
Stage -0,.05 -0.. 11 -0..06 0..08 0 .08 0. 13
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Table 9. Correlations of patient variables with postoperative
concentrations of prealbumin and transferrin. Values in the table are
R, the Spearman rank order correlation coefficient.
"fc )lf
0.05>p>0.01 p < 0 .01 .
PRE 24 PRE 48 PRE72 TRF 24 TRF 48 TRF 72
Age -0.37 -0.21 -0.26 -0.49* -0.26 COCOo1
Weight 0.15 0.13 0.15 0.08 -0.31 -0.35
Wt loss -0.14 -0.15 -0.14 -0.24 CT»(NO1 -0.31
Height -0.00 0.30 -0.11 oo1 -0.06 -0.33
MAC 0.16 0.05 0.17 0.14 -0.17 -0.16
TSF 0.04 -0.10 0.04 -0.08 -0.27 -0.21
Albumin 0.31 0.23 0.16 0.38 0.33 0.26
Duration -0.34 -0.17 -0.12 -0.09 -0.37 -0.37
Stage -0.35 -0.31 -0.33 -0.35 -0.14 -0.04
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3. Comparison of groups 2,3 and 4
Table 10, page 108 compares the patients in groups 2,3 and
4 to establish their comparability using nutritional and
other criteria. It is noticeable that there are no
statistically significant differences in the nutritional
variables between patients in any of the three groups
(except weight).
Figures 8 - 12, pages 109 - 113 show the levels of
the 5 proteins measured by group of the study. In each of
the 5 graphs there are no statistically significant
differences between any of the corresponding time points
(Mann Whitney U).
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Table 10. A comparison of patients from groups 2,3 and 4 showing
nutritional indices stage of disease and duration of operation.
Values are median (Q1-Q3). Disease stages are defined on page 68.
Group 2 3 4
Age (years) 68 (57-70) 67 (56-72) 72 (68-76)
Weight (kg) 69 (47-74) 60 (52-65) 53 (42-55)
Weight loss (%) 0 (0-0) 11 (11-13) 13 (10-16)
MAC (mm) 271 (221-275) 252 (204-257) 240 (211-257)
TSF (mm) 9.2 (5.6-10.8) 6.4 (3.1-10.6) 6.8 (3.9-8.5)
Albumin (g/1) 42 (36-44) 39 (34-41) 37 (35-39)
Stage of disease 4 (2-4) 4 (3-4) 4 (2-4)
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Figure 8. The time course of plasma C-reactive protein
concentration (median, Q1-Q3) following operation for
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Figure 9. The time course of plasma alpha-j-antitrypsin
concentration (median, Q1-Q3) following operation for
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Figure 10. The time course of alpha^acid glycoprotein
concentration (median, Q1-Q3) following operation for
groups 2, 3 and 4.
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Time (hours)
Figure 11. The time course of plasma prealbumin
concentration (median, Q1-Q3) following operation
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Figure 12. The time course of plasma transferrin
concentration (median, Q1-Q3) following operation for
groups 2, 3 and 4.
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2. THE IN VITRO STUDY
The experiments reported in this section attempt to
test the validity of using the liver slice as a model for
studying the acute phase reaction in vitro and then seek
evidence for the influence of nutrition on the observed
responses.
Incubation of the liver samples
Liver incubations were carried out on tissue
specimens from 40 patients in total, 19 from group 1, 9
from group 2, 7 from group 3 and 5 from group 4. Details
of these patients are to be found marked '#' in tables 3 -
6, pages 92 - 95.
A further 7 patients had biopsies taken but no
results are available. Two had their liver samples grossly
contaminated by overgrowth of bacteria and the results
discarded and in 5 no incubations were carried out due to
technical problems at the stage of slicing the liver
leading to maceration rather than slicing. These 5
occurred with small biopsy specimens in the early attempts
at slicing before a reliable technique was established for
fixing the liver specimen to the platter of the Mcllwain
tissue slicer.
The weight of the liver tissue obtained varied
between 0.24 and 2.16 g and was entirely at the discretion
of the operating surgeon. No complications occurred in any
patient as a result of the biopsy procedure.
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The number of incubation dishes which could be set up
from each biopsy varied between 2 and 6, depending on the
size of the trimmed specimen and the success of the
slicing procedure. This was technically the most difficult
stage of the preparation of the incubation dishes and was
dependent on the degree of fixation of the sample to the
platter. Movement of even a minor degree of the specimen
coupled to the inherent lack of rigidity of liver
parenchyma resulted in considerable variation in the
thickness of the liver slices which was readily apparent
to the naked eye even at a nominal slicing thickness of
0.4 mm. This is likely to have had considerable
implications for the nutrition and oxygenation of the
liver parenchymal cells during incubation.
Intracellular CRP levels
In order to establish that the CRP appearing in the
incubating medium was indeed newly synthesised, the CRP
content of fresh liver was measured in 15 samples of
liver. The median amount of CRP present was 3.57 x 10-^
mcg/mg wet liver (Q1-Q3, 2.58 - 4.80; range 1.7 - 7.7).
In addition the intracellular content of 8 samples of
liver was measured at the end of the incubation in phase 2
(all incubated with 10 U/ml IL-1) to ensure that the
amount of CRP seen in the medium represented all the newly
synthesised CRP. The median amount present was 5.26 x 10
mcg/mg wet liver (Q1-Q3, 3.21 - 10.62). Although this
is greater than concentration of intracellular CRP
measured before incubation, it indicates that most of the
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newly synthesised CRP was being released into the medium.
Effect of interleukin-1 on CRP production
Every sample of liver obtained was incubated both
with and without the presence of interleukin at a
concentration of 10 IU/1. The results are shown in figures
13 and 14, pages 117 and 118, showing production of CRP
from liver slices in the presence and absence of IL-1 in
both the air/C02 and 02/C02 phases respectively. In phase
1 the median CRP released into the medium rose from 7.48
to 11.85 x 10-^ mcg/mg (p = 0.008; Wilcoxon) and in phase
2 from 93.3 to 137 x 10"^ mcg/mg (p < 0.001; Wilcoxon).
The median of the difference of pairs expressed as a
percentage of the first of the pair was 84%.
The maximum amount of CRP released into the medium by
interleukin-1 stimulated liver slices was 432 x 10-^ meg
CRP/mg wet liver. Extrapolating by weight this would
represent 64.8 mg CRP from a whole 1.5 kg liver. Diluted
in 5 litres of serum this would give a concentration of
approximately 13 mg/1 ignoring the effect of degradation
and consumption of CRP. This is only a few fold above
basal levels in man suggesting that the liver slices
function ineffectively in synthesising CRP compared to
intact liver. The levels are however more than 100 fold













Figure 13. The effect of 10 U/1
production from liver slices in
(Wilcoxon)
interleukin-1 on




Figure 14. The effect of 10 U/l interleukin-1 on CRPproduction from liver slices in phase 2. n = 27; p < 0.(Wilcoxon)
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Dose response of interleukin-1
The dose response relationship of interleukin-1 was
investigated in 14 incubations, by varying the dose of
IL-1 between 1 and 20 U/ml in steps of 1, 5, 10 and 20
U/ml. Due to either the absence of sufficient IL-1 or low
yield of slices, not every increment was used on each
occasion. Figure 15, page 120, plots the results obtained.
This initially confusing graph has certain patterns.
1. There is no significant difference between control
samples and those stimulated with 1 U/ml IL-1. This dose
was abandoned after the first 5 results were available.
2. Five U/ml produced significant stimulation compared to
control values.
3. Ten U/ml produced significant stimulation compared to
control values.
4. Ten U/ml produced more stimulation than 5 U/ml but this
was not statistically significant.
5. There was little difference between 10 U/ml and 20 U/ml
(although with 2 very high results), and this was not
statistically significant.
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Figure 15. The effect of increasing concentrations of IL-1
in the incubating medium on CRP production of incubated
liver slices. The statistical analysis is described in the
text. The asterisks represent points at 647 and 681
mcg/mg x 10 CRP.
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All values are median (Q1-Q3) CRP production in mcg/mg wet
liver x 10"^, and p value by Wilcoxon.
Control v 1 U/ml;
95 (6.4-100) v 90 (4.5-201) n = 5 ns
Control v 5 U/ml;
103 (9.3-95.5) v 161 (16.9-132) n = 12 p = 0.012
Control v 10 U/ml;
103 (9.3-95.5) v 192(20.4-156) n = 12 p < 0.01
5 U/ml v 10 U/ml;
161 (16.9-132) v 192(20.4-156) n = 12 p = 0.45
10 U/ml v 20 U/ml;
160 (90.6-194) v 145 (77.5-200) n = 11 p = 0.85
Effect of varying the oxygenation of the tissue slices
The liver slices were initially incubated in an
atmosphere of 95% air/5% CC>2 (phase 1). This was later
changed to an atmosphere of 95% 02/5% CO2 (phase 2) in
order to improve the preservation of the liver cells. The
change of gas phase had a considerable effect on the
amounts of CRP produced. Figure 16, page 122 shows the
distribution of CRP production in samples incubated for 24
hours in the presence of 10 U/ml interleukin-1 for phase 1
and phase 2. The improved oxygenation had a clear effect
on CRP production, increasing median CRP production by
approximately 13 fold, from 10.8 to 137 x10-^ mcg/mg wet
liver (p < 0.001; Mann Whitney U). This must be taken into
account when other aspects are analysed since phase 1 and















Figure 16. The effect of increasing the tissue oxygenation
on the CRP production of liver slices incubated for 24
hours (phase 1 (n = 14) v phase 2 (n = 27)). p < 0.001
(Mann Whitney)
- 122 -
Time course of CRP production
The initial incubations were carried out in an
atmosphere of 95% air, 5% C02 and for 24 hours. In 2 sets
of experiments this period was extended to 96 hours, and
measurements were made of the CRP concentration in the
medium every 24 hours. At each of the specified time
intervals 0.5 ml of medium was removed and replaced with
0.5 ml of fresh DMEM with or without FCS but without
further interleukin-1 thus slightly altering the
composition, diluting products of metabolism and IL-1 and
renewing substrate supply.
The amount of CRP present in the medium at each time
interval is shown in figures 17 and 18 (pages 125 and
126). Each graph represents several incubations from a
single patient with varying composition of the medium. It
can be seen that CRP production continued to rise in a
near linear fashion for 96 hours. This suggests that the
hepatocytes in the culture remained viable throughout this
period. This is at variance with the histological evidence
detailed below.
The early time course of CRP production was also
studied by measuring both intracellular CRP and CRP
released into the medium at intervals of 2, 4, 6 and 24
hour of incubation using the last patient from phase 1.
The results are shown in figures 19 and 20, pages 127 and
128, representing the control and IL-1 stimulated liver
slices. It can be seen that there is a lag phase with
little increase in the total amount of CRP present within
first 4-6 hours. This is in keeping with the similar lag
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phase known to occur in the in vivo acute phase reaction.
These graphs also show that the intracellular CRP is not






Figure 17. The time course of CRP production of eight
incubated liver slices from patient no 9. Although there
are differences in the composition of the medium CRP
synthesis continues for 96 hours in all the slices
incubated.
- 125 -
0 24 48 72 96
Time (hours)
Figure 18. The time course of CRP production of seven












Figure 19. The early time course of CRP production in
parallel incubations from patient no 17 without exogenous
IL-1 . Crp = total CRP; CM = CRP released into the







Figure 20. The early time course of CRP production of
parallel incubations from patient no 17 in the presence of
10 U/1 IL-1 . ILrp = total CRP; IL« = CRP released into the
incubating medium; ILj = intracellular CRP.
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Effect of foetal calf serum on CRP production
The effect of the presence in the medium of foetal
calf serum was investigated in 20 subjects, 6 from phase 1
and 14 from phase 2, who had paired incubations set up
with and without foetal calf serum. Neither of the pair
contained interleukin-1.
There was no significant difference between the pairs
when analysed altogether or separating phase 1 and phase 2
incubations. These results are shown graphically in figure
21, page 130.
From 13 of this group of 20 subjects incubations were
also set up with 10 IU/1 interleukin-1 both with and
without FCS, thus having four parallel sets of incubations
(with and without IL-1, with and without FCS) under
otherwise identical conditions. The results of these are
shown in figure 22, page 131.
The statistics are as follows. All values are median
(Q1-Q3) CRP production in mcg/mg wet liver x 10-^. Groups
compared by Wilcoxon.
FCS+/IL1- V FCS-/IL1- 95 (14-115) V 1 01 (21-190) ns
FCS-/IL1+ V FCS-/IL1- 1 27 (18-159) V 1 01 (21-190) ns
FCS+/IL1+ V FCS+/IL1- 192 (25-258) V 95 (14-115) P = 0.001
FCS+/IL1+ V FCS-/IL1+ 192 (25-258) V 1 27 (18-159) P < 0.01
FCS+/IL1+ V FCS-/IL1- 1 92 (25-258) V 101 (21-190) P < 0.05
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Figure 21. The effect of foetal calf serum on the
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Figure 22. The effect of foetal calf serum both with and
without interleukin-1 in parallel incubations. The
statistical analysis is described in the text.
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The results shown in the preceding graphs may be
summarised as follows;
1. FCS had no significant effect on unstimulated liver
2. IL-1 had no significant effect in the absence of FCS
3. FCS together with IL-1 stimulated CRP production
compared with only one of these or neither.
Cell Viability
Cell viability and preservation during the incubation
period was assessed by 3 methods.
1. Trypan blue staining.
The results obtained by tissue digestion and trypan
blue staining were uniformly unhelpful. Four sets of liver
samples were examined by this method. Despite carefully
following the method recommended by the manufacturer of
the trypan blue, all samples showed total fragmentation of
all the cells with no intact cells seen. Since this did
not accord with the biochemical evidence of continuing CRP
production by these cells this method was abandoned early
in the course of the experiments, in the belief (probably
erroneous) that the fragmentation was being caused by the
trypsin digestion and centrifugation processes rather than
the conditions of handling and incubation of the liver
tissue.
2. Comparison of intracellular enzyme activity of fresh
liver tissue and the liver slices at the end of the
incubation period.
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Ten pairs of enzyme levels were measured, all from
the 02/C02 phase of the study. Table 11, page 134 gives
the levels of phosphofructokinase, fructose 1,6-
diphosphatase and hexokinase before and after incubation,
and table 12, page 135 expresses the post incubation
levels as a percentage of the pre incubation levels. The
post incubation samples were all incubated in the presence
of interleukin at a concentration of 10 IU/1.
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Table 11. Intracellular glycolytic enzyme levels in liver tissue
before and after incubation. Values are mcmol product/min/g wet
liver. PFK = phosphofructokinase, FDP = fructose 1,6-diphosphatase.
Study number PFK FDP Hexokinase
pre post pre post pre post
38 5.33 2.51 4.84 2.59 1 .82 1.13
39 4.46 0.14 3.92 0.58 0.64 0.23
42 4.93 1 .60 4.25 3.51 0.70 0.64
43 6.42 1 .75 8.07 1 .71 0.91 0.46
44 3.66 2.99 4.74 4.36 0.76 0.76
45 4.28 1 .52 4.37 3.74 0.68 0.63
51 4.74 3.07 3.32 2.99 0.52 0.43
53 4.46 3.57 3.40 3.07 1.16 0.79
54 5.75 1 .67 5.13 1 .67 1 .20 0.82
55 2.43 1 .78 2.43 1 .60 0.58 0.46
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Table 12. The post incubation glycolytic enzyme levels expressed as a
percentage of pre-incubation levels. PFK = phosphofructokinase, FDP =
fructose 1,6-diphosphatase.
Study no PFK FDP Hexokinase
38 47 54 62
39 3 15 36
42 32 82 91
43 27 21 11
44 82 92 100
45 36 86 93
51 65 90 83
53 80 90 68
54 29 33 68
55 73 66 90
Median 41 74 75
Q1-Q3 28-77 27-90 49-90
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3. Histology of the liver slices
Histological examination was performed on
representative samples of liver from both the air/CC^ and
02/C02 phases and after various time periods of
incubation. Samples of liver were also examined after
slicing and before incubation to examine the effects of
the slicing procedure on the hepatic parenchymal cells.
Prior to incubation the cells were histologically
normal apart from showing some slight degree of fatty
vacuolation commonly seen following a period on
intravenous nutrition [Tulikoura and Huikuri, 1982].
Trauma to the cells was confined to the extreme periphery
of the slices.
In the air/CC>2 phase of incubations there was rapid
and generalised deterioration in the histological
appearances of the cellular structure. The progression of
changes is shown in plates 1 - 5, pages 228 - 230, from
patient number 17. The histological appearances were
reported as follows;
1. Fresh specimen. "Normal liver in which most cells
contain stainable glycogen." (plate 1)
2. Two hours. "Although cytologically the liver cells
appear normal there is diminished glycogen content."
(plate 2)
3. Four hours. "There is now a definite increase in
eosinophilia in periportal and midzonal (Acinar zones 1
and 2) hepatocytes associated with nuclear chromatin
condensation indicative of early pyknosis. In contrast the
centrilobular (zone 3) cells are pale with normal nuclear
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morphology, in some areas the glycogen content is slightly
greater in zone 3 than in zones 1 and 2, but this is not
consistent." (plate 3)
4. Six hours. "Most cells in zones 1 and 2 show
eosinophilia and nuclear pyknosis. Zone 3 cells remain
pale and have normal nuclei." (plate 4)
5. Twenty four hours. "The liver is totally necrotic. Some
pyknotic nuclei persist mainly in zone 3, but elsewhere
the cells are eosinophilic 'ghosts' showing gradual
disappearance of nuclei by karyolysis." (plate 5)
Similarly liver from study number 15 was reported as
follows;
Fresh specimen. "The liver biopsy shows non specific
changes of mild fatty change and a focal mild acute
inflammatory infiltrate. The architecture appears normal."
Twenty four hours. "The liver cells are completely
necrotic. There are no viable hepatocytes."
Six samples in all were examined from phase 1 and all
showed complete necrosis at 24 hours.
In phase 2 the liver samples were considerably better
preserved though there was a great deal of variation from
slight to almost complete necrosis by 24 hours. Examples
are described below. Study number 28 (plates 6 - 10, pages
230 - 232) is reported as follows;
1. Fresh specimen. "Within normal limits", (plate 6)
2. Twelve hours. "About 20% of hepatocytes are necrotic.
The necrosis is confluent and mainly involves zone 3 cells
but in at least one place necrotic cells surround a portal
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tract." (plate 7)
3. Eighteen hours. "20 - 30% necrosis in this sample
principally involving zone 1." (plate 8)
4. Twenty four hours. "About 10% necrosis seen around the
biopsy margins and in periportal zones." (plates 9 and
10) .
The fact that there was a greater degree of ncrosis
recorded at 18 hours than at 24 hours indicates the
variability of preservation. This is probably accounted
for by the variability of trauma and slice thickness
produced at the slicing stage.
By contrast study number 25 is reported;
1. Fresh specimen. "Normal apart from some crush artefact
around the margins."
2. Eight hours. "About 80% degenerate - all zones."
3. Twenty four hours. "Totally necrotic."
Fifteen samples from 8 patients were examined in
total from phase 2. The median fraction of necrotic cells
after 24 hours incubation was 55%.
Reproducibility
Twenty six liver samples were incubated in pairs
under identical conditions of medium and oxygenation in
order to test the reproducibility of the incubation
process. The CRP production from the pairs has been
plotted in figure 23, page 139 with the lesser amount on
the X-axis and the greater value on the Y-axis. The line
of best fit has a slope of 1.27, Rs = 0.968, p < 0.001
(Spearman's rank order correlation coefficient). The
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Figure 23. Correlation of values of CRP production from
pairs of liver slices incubations under identical
conditions of medium and gas phase. The lesser values are
on the X-axis. Rs = 0.968, p < 0.001; Spearman.
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median of the differences between pairs expressed as a
percentage of the first of the pair was 29%, which is
considerably less than the differences produced by either
the change in the gas phase of the incubation, or the
addition of interleukin-1 , which were approximately 1300%
and 84% respectively.
Influence of nutrition on CRP production
Due to the change in methodology in the middle of the
study altering the gas phase of the incubation conditions
with its pronounced effect on CRP production, some
difficulty has been encountered in this analysis. The
already small numbers in each arm are therefore divided
into two non comparable groups. The numbers are:
group 1 19 (7 in phase 1 and 12 in phase 2)
group 2 10 (2 in phase 1 and 8 in phase 2)
group 3 7 (3 in phase 1 and 4 in phase 2)
group 4 5 (2 in phase 1 and 3 in phase 2)
Comparisons between groups with such small numbers would
not be expected to show significant differences and does
not (data not shown). Therefore an analysis of the results
has been carried out by correlation between the
nutritional indices and CRP production in interleukin-1
stimulated liver. This has been performed separately for
phase 1 and phase 2. The correlations are listed in table
13, page 141. Only 2 out of 20 correlations have achieved
statistical significance at the 0.05 level. This may have
arisen by chance. Interestingly the correlation with
weight had a negative value.
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Table 13. Correlations of nutritionally related variables with CRP
production from interleukin-1 stimulated liver in vitro. Values are


























Hauf his soul a Scot maun use
Indulgin' in illusions,
And half in gettin' rid o' them
And comin1 to conclusions
Hugh Macdiarmid
from A Drunk Man Looks at the Thistle
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1 . DESIGN OF THE STUDY
The assumptions on which this study was based were
that;
i) malnutrition causes disordered organ function and
delayed healing leading to an increased incidence of
morbidity and mortality in patients undergoing operations
ii) the acute phase reaction and in particular the plasma
protein changes seen after trauma and sepsis appear to be
a significant part of the process of repair and resolution
of inflammation and infection.
The hypothesis was therefore made that a reduction in
the magnitude of the acute phase reaction might be
expected in malnourished patients and that this might
contribute to the increased incidence of complications and
mortality. The aim of this study was to test the first
part of this hypothesis.
The simplest way to do this was to measure acute
phase proteins in the plasma of patients undergoing
operation and to relate the plasma concentrations reached
to the nutritional status of the patients.
However, since the magnitude of the operation in
itself was likely to be a major determinant of the
magnitude of the acute phase reaction it was necessary to
standardise the degree of surgical trauma as much as
possible. This would have been relatively easy by choosing
an operation such as herniorrhaphy or cholecystectomy
where the degree of dissection should be quite similar in
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most patients. However no two surgical operations are
exactly the same and more so is this true when multiple
operators are involved.
Operations such as herniorrhaphy and cholecystectomy
are only rarely knowingly carried out on patients with
significant degrees of malnutrition and it was therefore
not appropriate to choose such operations. In order to
find an elective operation which is commonly carried out
in the presence of malnutrition it was necessary to look
at the upper gastrointestinal tract and malignant disease
in particular.
Gastro-oesophageal cancer is a particular interest of
the University Department of Surgery at the Leeds General
Infirmary and a large number of operations for this
condition are carried out each year. In the department I
had already set up a clinical trial in which patients with
upper gastrointestinal cancer who were deemed to be
malnourished as defined by the loss of 7.5% of recall body
weight were randomised to receive 7 days of intravenous
nutrition or to act as controls. I therefore decided to
use these patients as subjects for the study. In addition
a group of patients undergoing surgery for the same
condition but without weight loss was also recruited.
Gastro-oesophageal carcinoma is commonly a cause of
significant malnutrition by the nature of the disease, and
yet surgery must proceed before this malnutrition can be
fully or even partially in some cases corrected.
Unfortunately operations for gastro-oesophageal carcinoma
represent a quite wide range of degrees of surgical
- 144 -
trauma. Even when a rigid protocol of tumour and lymph
node excision is followed the length and nature of the
dissection depends on the experience and skill of the
operator, the build of the patient, the presence of
adhesions from previous surgery, the fixity of the primary
tumour, the presence of enlarged lymph nodes, either
reactive or due to secondary deposits, amongst other
factors. For these reasons, ensuring a standard degree of
surgical trauma was not a realistic expectation.
An attempt to analyse results within groups
stratified to allow for these variables would lead to
impossibly small numbers for any realistic hope of
achieving statistical significance.
Another factor which masks the role of nutrition is
that component of the acute phase reaction produced by
pre-existing or early developing infection in patients
after major upper gastrointestinal tract surgery, who have
a higher incidence of chest and anastomotic infection
problems than in lower gastrointestinal tract surgery for
instance. There is no method of making an allowance for
this when comparing plasma protein concentrations.
For these reasons, I did not feel that the
measurement of plasma proteins post operatively was likely
to be sufficient in itself to determine whether
nutritional status was exerting an influence on the acute
phase reaction unless nutrition was the dominant
determinant of the magnitude of the acute phase plasma
protein response. Nevertheless since I thought that this
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problem had not been previously addressed I decided to
proceed with this part of the study.
The plasma protein study was designed initially with
the expectation that only CRP would be measured, this
being the archetypal acute phase protein, easily measured
and fast reacting. The intervals at which blood samples
were obtained namely at 12, 24, 36, 48 and 72 hours post¬
operatively was determined by this expectation, in order
to observe the expected rise, peak and initial fall of CRP
plasma concentration. For many patients having their
operation in the afternoon the 12 and 36 hour blood
samples fell due in the middle of the night. These samples
were only taken from patients who had indwelling vascular
access which allowed blood sampling without disturbing the
patient. This accounts for the reduced number of samples
from these times.
After the study was commenced the oppertunity to
measure further plasma proteins became available. The
proteins measured were one rapidly reacting acute phase
protein (CRP), two more slowly reacting proteins (AAT and
AAG) and as a contrast two 'negative acute phase
reactants1, the transport proteins transferrin and
prealbumin. CRP was expected to peak at 48 hours post¬
operatively and the other two reactants at 72 hours or
later. Had it been anticipated that I would measure all
five proteins from the outset a further one or two days
blood samples would have been taken to be sure of reaching
the peak plasma concentration of the slower responding
reactants.
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For the reasons outlined above, a second arm to the
study was required which could assess the ability of the
patient to mount an acute phase response independent of
the operative and postoperative influences referred to,
and yet would reflect the preoperative condition of the
patient.
The acute phase plasma protein response has two
stages, firstly the production of cytokines from
macrophages at the site of inflammation and injury, and
secondly the stimulation of the liver by these cytokines
to synthesise acute phase proteins. At least two groups of
workers have shown that malnutrition produces an
attenuated response of macrophages to stimuli of IL-1
synthesis and release (see chapter 3 of the introduction).
It therefore seemed obvious to study the second stage of
the response by looking at the effect on liver of a
standardised stimulus in vitro under controlled laboratory
conditions.
A liver biopsy taken at the beginning of operation
just after the abdomen is opened afforded the ideal
material for study. The amount of liver required could
only be obtainable by open liver biopsy. Although this
might be regarded as a hazardous procedure for patients to
undergo for purely research purposes, experience has shown
that this is not so in practice. There is a long tradition
in the Leeds General Infirmary of research carried on
liver samples obtained this way without mishap. The
principle hazards of the procedure are the risks of
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haemorrhage or bile leak from the cut surface of the
liver. Provided the biopsy is carried out properly the
risk is low and if carried out at the beginning of a long
operative procedure any such problem should be noticed and
dealt with by standard means before the abdomen is closed.
The only incident related to the biopsy in this series was
in a patient who developed liver necrosis and abscess
formation requiring relaparotomy. At re-operation the
liver necrosis although in the region of the biopsy site
was of such a size, greater than a hundred times the
volume of the biopsy, that I was confident that the biopsy
was not the cause. This patient had had a radical
lymphadenectomy from around the hepatic artery carried
high into the porta hepatis suggesting that the cause of
the liver necrosis was ischaemia due to vascular damage
during the dissection and this was also the opinion of the
operating surgeon. Thus I am satisfied that no harm
occurred to any patient due to the experimental procedure.
I then had to decide in what way to process the liver
sample so obtained. The first possibility considered was
to attempt to culture the cells. This was fairly easy to
dismiss since culture of normal human hepatocytes had not
been previously achieved. In any case the establishment of
stable cell cultures would tend to remove the
characteristics which reflect the nutritional status of
the patient from which the sample was obtained.
The next question was whether to maintain the
architecture of the liver intact by using thin slices of
liver or whether to attempt to produce a single cell
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suspension or an acellular homogenate. Since IL-1 was
thought to produce its action via a cell surface receptor
and to require an intact system of transcription of mRNA
the acellular homogenate was rejected. At the time of
designing the experimental method it was still not certain
whether IL-1 was acting directly on hepatocytes or whether
a second messenger produced in the Kupffer cells was
required, and if so whether an intact liver architecture
would be required. For this reason it was decided to use
liver slices as the model.
There was in the department a purpose built machine
for this purpose the Mcllwain tissue slicer [Mcllwain and
Buddie, 1953] and this was used to produce the liver
slices. In practice it proved not to be an ideal tool.
Difficulty in fixing the specimen to the platter was
experienced and a number of methods of fixing the specimen
were tried including the use of agar, wetting the platter
and finally allowing the liver to dry slightly on a piece
of filter paper which was then attached to the platter
with metal clips. Time on the platter is 'warm ischaemia
time' being out of the iced saline and variability here
could only affect the preservation of the cells quite
considerably, both from the effect of temperature and
desiccation. The Mcllwain slicer is more suited to the
slicing of tissue that is less sensitive to warm ischaemia
and is firmer in consistency so that it may be sliced more
consistently. These difficulties have been recognised
before and an improved slicer has been described
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[Krumdieck, 1980]. Using this device human liver slices
have been produced with a consistent measured thickness
and incubated with virtually complete histological
preservation at 20 hours [Smith et al, 1985]. Attempts to
find a manufacturer for this device proved fruitless
despite contacting the original designer directly.
The next problem to be addressed was the duration of
incubation. CRP is not stored in hepatocytes but
synthesised de novo which involves a lag phase of at least
6 hours. It was not known what the rate of protein
synthesis would be in this model and I did not know how
long it would take to synthesise sufficient CRP to be
detectable by the assay which had a sensitivity of 0.1
mcg/1. The duration of incubation required was important
in deciding the conditions under which to maintain the
liver slice. The period chosen was 24 hours initially but
in early experiments I extended this to 96 hours in 4
patients (nos 8 - 11). When the results of histological
examination were obtained showing the destruction of the
liver architecture and phase 2 was started the period was
restricted to 24 hours.
The medium chosen was a standard commercially
available one the use of which for maintaining hepatocytes
is well documented [Baumann et al, 1984]. Dulbecco's
modified Eagle medium (DMEM) uses bicarbonate as a
buffering system which dictated the need for an atmosphere
containing 5% CC>2 to maintain the pH of the medium at 7.4.
I elected on the grounds of simplicity to use a 95%
air/5% CC>2 atmosphere for the initial incubations which
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could be provided automatically in an incubator which was
in our laboratory. Evidence that this would maintain a
significant proportion of hepatocytes within liver slices
for a period of at least 24 hours was found in previous
work from Cambridge using rat liver, where necrosis
occurred between 24 and 48 hours [Campbell and Hales,
1971]. This in retrospect was an error which had
significant consequences for the success of the project.
A controversial area was the need for a natural serum
in the incubating medium. Although necessary for the
prolonged culture of some tissues due to the requirement
for as yet unidentified factors, the unknown contents of
sera such as foetal calf serum (FCS) has led to a desire
to dispense with these wherever possible in order to have
only precisely defined elements in the medium [Taylor,
1974]. Three questions arose with regard to my experiment.
Firstly did the IL-1 require to be cleaved to smaller
fragments before it would become active, as had been
suggested for its proteolysis inducing action [Clowes et
al, 1986], Secondly, did the FCS contain any cytokines or
substances which might induce cytokine production in
Kupffer cells? Although the FCS is tested for endotoxin
many other potent stimulators of the acute phase reaction
may have been present. Thirdly, did the FCS contain any
IL-1 inhibitors? These had been detected in human urine
[Liao et al, 1984; Liao et al, 1985] and presumably must
be present in plasma too. Since it was not clear what the
effect of FCS would be in my system, I elected to carry
- 151 -
out parallel incubations both with and without the
addition of 5% FCS.
The dose of IL-1 to be added was decided from
previous work on hepatocyte cultures. Since the release of
some IL-1 from the Kupffer cells within the slices could
not be excluded or allowed for then a supramaximal
stimulus was required in order to standardise the response
even if this was not a reflection of what would occur in
vivo in the postoperative state. Work with cultured mouse
hepatocytes and recombinant human IL-1 had suggested
[Ramadori et al, 1985] that maximal stimulation was
obtained by a dose of approximately 10 U/ml IL-1 and so
this concentration of IL-1 was adopted. The use of an even
higher dose to ensure that the stimulus was supramaximal
was prevented by the price of recombinant IL-1. Every
incubation dish required £15 of IL-1 at 1987 prices and up
to 6 dishes were incubated per patient. In a small number
of incubations a dose response curve was produced by
using concentrations varying between 1 and 20 U/ml to
check the validity of the assumption.
Testing of the maintenance of cell viability was
initially attempted by the method of trypan blue staining.
This works on the principle that after separation by
trypsin digestion only intact viable cells will take up
the dye trypan blue. When the stained cells were examined
under the microscope only fragmented cells were seen, and
this was erroneously thought to be due to destruction at
the trypsinisation or centrifugation stages of the
procedure. I was encouraged in this view by the initial
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assays of CRP given off by the incubated liver slices
which continued to increase in a linear fashion for 96
hours (see figures 17 and 18, pages 124 and 125).
With presumed failure of the method of trypan blue
staining, histological examination was used to look at the
liver slices. This was not used initially since it was
thought not sensitive enough to detect the subtle changes
in morphology that might affect function. Unfortunately
histological examination showed that frank necrosis of the
hepatocytes had taken place well within 24 hours. I felt
that with such gross necrosis it would be difficult to
extrapolate the activity of these slices to events in vivo
and therefore a revision of the method was reguired after
14 sets of incubations had been carried out.
The technique of organ culture has been applied to
several types of tissue with variable degrees of success
related principally to the degree of metabolic activity of
the tissue concerned, with metabolically less active
tissue such as cartilage, bone and prostate having greater
success in maintaining stable tissue specimens than more
demanding tissues such as muscle, kidney and particularly
liver which has been the most difficult tissue to maintain
for extended periods of time. In order to improve the
preservation of my liver samples previously described
methods which had been successful in maintaining
histologically normal mammalian liver for periods of up to
six days were adopted. The principle improvement was to
increase the oxygenation of the hepatocytes, thought to be
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the most critical factor in maintaining cellular
integrity, thus achieving better preservation of the liver
slices.
The liver slices were therefore suspended at the
surface of the liquid by mounting them on a stainless
steel mesh. By bending a small strip of this mesh a flat
platform was created just under the surface of the medium
maintaining the explants at the gas/liquid interface.
Similar platforms were described by Trowell in the first
definitive description of organ culture methods [Trowell,
1958]. The alternative to suspending the cells at the
gas/liquid interface was to maintain the medium and tissue
slice in continuous motion to ensure uniform gas
distribution throughout the medium. Such systems have been
widely described [Balls and Clothier, 1983; Smith et al,
1985]. In addition the atmosphere was altered to
95%02/5%CC>2 by placing the incubation dishes, mounted on a
specially made perspex holder, in a standard Mcintosh
Fieldes anaerobic jar and filling the jar with a premixed
gas of the appropriate composition. Subsequent
histological examination showed marked improvement in the
morphology of the liver slices at the end of the
incubation period, though this remained inconsistent and
imperfect (see pages 136 et seq) and inferior to
previously described work.
In order to demonstrate the degree of functional
preservation of the liver the activity of 3 enzymes
important in the glycolytic pathway were determined before
and after incubation. The enzymes were chosen from their
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central role in cellular metabolism and because there was
experience within the department of their measurement
[King efc al, 1981]. Table 11, page 134 shows the absolute
values obtained and table 12, page 135 expresses the post
incubation activities as a percentage of the pre
incubation levels. Interestingly phosphofructokinase (PFK)
was less well preserved than the other two which
maintained about 75% of preincubation activity, though
again there is considerable variation between experiments
varying between 3 and 82% for PFK and 36 and 100% for
hexokinase which was the best preserved. The varibility in
biochemical preservation thus reflected the variation in
architectural preservation seen on histological
examination. Unfortunately a slice could not be both
examined histologically and have enzyme assays carried out
due to the small size of the slices approaching the limit
of sensitivity of the assay and so no direct comparison
was possible.
From the above discussion it will be seen that a
major difficulty in carrying out this study was the need
to alter the experimental method after a number of
patients were recruited. I started the study before
knowing how best to carry it out. Once started I was then
reluctant to change the incubation methods since this
would destroy the comparability of the experiments before
and after any change was made, and this was only done once
it was clear that the tissue necrosis was so severe as to
bring into question the validity of the method. This
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effectively made the first phase of the work a pilot study
the results of which were not strictly comparable with the
second phase.
Had a limitless supply of patients suitable for
recruitment been available this would not have been
important. However, the numbers of patients who could be
recruited in the two year period which it was anticipated
would be available for this study were not high. In
practice many suitable patients could not be recruited,
mostly due to unwillingness to give permission for liver
biopsy, but also because of technical failures, especially
of the slicing mechanism, and running out of reagent (the
interleukin-1 was delivered on a regular weekly basis on
account of its limited shelf life which did not always
match the supply of patients).
The power of the statistical analysis which could be
carried out to address the original guestion of the
influence of nutrition was thereby compromised by the
small numbers in the two phases of the study.
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2. RESULTS OF THE IN VIVO STUDY
Before examing the effect of nutrition on the
magnitude of the acute phase plasma protein response I had
to establish firstly that a normal acute phase reaction
was being observed and secondly that the study group of
patients was malnourished.
The first of these was dealt with by comparing the
graphs on pages 98 - 102 with previously described graphs
of the time course of acute phase plasma protein
concentration following similar types of surgery. The rise
in median CRP from 0.6 mg/l, the lower limit of the assay,
to 144 mg/l is compared in table 14, page 158, with peak
levels seen in previously documented studies where the
acute phase plasma protein response had been followed
postoperatively. The measured levels vary considerably,
but a clear acute phase reaction with levels in the
expected range was seen in this series. The occurrence in
a few patients of CRP concentrations above the normal
range in the preoperative sample did not lead to higher
peaks of CRP. This has been noted by previous
experimenters [Colley et al, 1983].
The quantification of malnutrition is an imprecise
science for reasons that are outlined in section 3 of the
introduction of this thesis. The choice of weight loss as
the single criterion to select the malnourished population
depends on the conclusion that failure to maintain body
weight is the clearest indication of inadequate recent
nutrition. Although weight loss will be affected by the
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Table 14. Peak acute phase protein levels in this study
compared to previously documented series. All values are
mg/1.
Operation AAT AAG CRP
Mastectomy 63 a
Cholecystectomy 1 450 130 b
Herniorrhaphy 1 300 115 b
Various 5000 1600 165 c
Various c200 d
Gastrectomy 1 570 e
G-I resection 3900 1650 210 f
This study 3800 1190 1 44
a = Aronsen et al, 1972; b = Colley et al, 1983; c =
Fischer t al, 1976; d = Rapport et al, 1957; e = Werner
and Odenthal, 1967; f = Cruikshank et al, 1989.
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complex relationship between weight loss and malignancy
(see page 47), other nutritional markers will be also
affected by factors other than nutrition. The figure of
7.5% is an arbitrary one but represents approximately one
stone in a man of average build which would be regarded by
most people as a significant loss of weight in a three
month period.
However in the patients studied here this amount of
weight loss has not been accompanied by significant
differences in other accepted nutritional indices such as
mid arm circumference, triceps skinfold thickness or the
plasma concentrations of albumin and transferrin.
Unexpectedly there was no significant statistical
difference in actual weight between the group with weight
loss and those without, which suggests that the
malnourished group may possibly have started from a higher
basal weight than the no weight loss group. Another
possibility is that patients recall of actual weight and
weight loss is inaccurate and thus unreliable as a method
of assessing nutritional status. Nevertheless all the
nutritional parameters did trend in the direction expected
in the weight loss group and p values were close to the
0.05 level and would probably have achieved significance
with slightly greater numbers in each group.
When the plasma concentrations of the acute phase
proteins were compared in the groups as defined there was
no significant difference in the peak levels of CRP, AAT
or AAG and no discernible trend (figures 8 - 10, pages 109
- 111).
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In order to assess whether this result had arisen
because of an erroneous choice of a marker for
malnutrition, ie weight loss, I decided to seek
correlations between the measured nutritional variables
and the levels of acute phase plasma proteins in the post
operative period.
This should show any genuine association and avoided
the need for comparisons of groups selected on arbitrary
parameters of nutritional variables such as weight, weight
loss, anthropomorphic measurements or plasma albumin.
Correlations were also sought with duration of operation
as a measure of the operative trauma and stage of disease
since there is evidence that acute phase response may be
attenuated by malignant disease [Herman et al, 1984]. The
results are shown in tables 7 and 8 on pages 104 and 105.
Although some significant correlations do appear this
would be expected even on a random basis when this number
of correlations are performed and no consistent pattern
emerges. One unexpected trend was the inverse relationship
between both AAT and AAG concentrations and the duration
of operation.
Similarly when the transport protein profiles were
correlated in the same manner (table 9, page 106) no
consistent pattern emerged.
Since the experimental work on this study was
completed I have found two publications on the effect of
nutritional status on the acute phase response to major
surgery, one from the group in Milan who in 1984 announced
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that no study had been carried out [Dionigi et al, 1984]
and published shortly afterwards [Dominioni et al, 1984]
and a second from Glasgow published in 1989 [Cruikshank et
al, 1989]. Both purport to show a reduced acute phase
response in malnourished patients but in both the effect
is slight. The Glasgow group selected patients on the
basis of being underweight, i.e. less than 80% of ideal
body weight, without specifying actual weight loss. They
then measured CRP, AAT and AAG in their patients after a
variety of abdominal procedures. AAT and AAG showed no
difference but the peak CRP level was reduced by a
significant level p < 0.02. This is open to the criticism
that these subjects were thin normals rather than
malnourished. Also since weight reached a significant
correlation with CRP (but not with AAG or AAT) in this
study the results may be consistent ie lean normal
subjects may produce a lower peak of CRP concentration
than heavier subjects whether or not they are
malnourished.
The Milan group found a weak relationship with only
AAG (but not AAT or CRP) showing a significant reduction
in peak concentration compared to normal subjets after
gastrectomy when patients were selected on the basis of
serum albumin < 32 mg/l. No such relationship was seen in
the present study.
The reasons why no relationship has been demonstrated
between nutritional status and the magnitude of the acute
phase response need to be examined.
The first possibility is that there is no
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relationship between malnutrition and the acute phase
response, and that except in very advanced cachexia the
acute phase response is a favoured pathway of hepatic
protein synthesis at the expense of albumin and transport
proteins on account of the biological importance of acute
phase proteins in recovery from trauma and infection. This
suggestion has been made previously [Dionigi et al, 1984].
A second possibility is that a relationship does
exist but that it is weak and insufficient numbers of
patients have been recruited to demonstrate it. This
cannot be tested without doing the necessary experiment
with far greater numbers of patients.
It is also possible that a relationship exists which
is being masked by other factors influencing the acute
phase response, such as degree of surgical trauma and
tumour load which have not been adequately controlled for.
As I have discussed above a reproducible degree of
surgical trauma is not a real possibility except in very
minor procedures.
Finally it may be that the patients in this study are
not malnourished, that 7.5% loss of body weight does not
represent a sufficient loss of body tissue to justify the
term malnourished, and that an effect in the small numbers
of genuinely malnourished with greater degrees of weight
loss was masked by the patients with lesser degrees of
weight loss in the malnourished group. Unfortunately there
are insufficient numbers with large (> 15%) degrees of
weight loss to make a meaningful statistical analysis.
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3. RESULTS OF THE IN VITRO STUDY
The first objective with the liver slice incubations
was to establish that the liver samples were capable of
synthesising CRP, and that they were responsive to the
exogenous IL-1. This reguired firstly the assay of
intracellular CRP in fresh liver to ensure that CRP
released into the medium was not simply the release of
stored CRP and secondly the measurement of CRP production
from liver slices incubated in media both with and without
added IL-1.
Intracellular levels of CRP were found to be low in a
sample of specimens from 15 patients ranging from 1.7 to
7.7 mcg/mg wet liver (median 3.57; Q1-Q3, 2.58 - 4.8).
Complete and instantaneous release of this amount of CRP
from a normal liver of 1500 g into a circulating plasma
volume of 5 1 would result in a concentration of
approximately 0.1 mg/l which is well below the
concentrations seen with even mild acute phase
stimulation, consistent with the known evidence that the
rise in concentration of acute phase plasma proteins is
due to synthesis of new protein and not to release of
intracellular stores.
The levels of CRP in the medium at the end of the
incubation period from the 'unstimulated' liver slices (ie
those incubated in medium without the addition of
exogenous IL-1) was, however, greater than would have been
expected if no new synthesis of CRP had taken place.
Therefore these apparently unstimulated pieces of liver
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had also begun to synthesise CRP. Three sources for
inducers are thought possible. Firstly that, before being
removed, the liver tissue had been exposed to IL-1 or
other cytokines which had been induced by the trauma of
laparotomy. Secondly, that cells damaged by the trauma of
harvesting the biopsy or by the ischaemia during
incubation had activated Kupffer cells within the liver
slice to produced new cytokines. Thirdly that the medium
bathing the liver slices contained some substance which
was activating the acute phase reaction either by a direct
action on hepatocytes or indirectly via Kupffer cells.
It is not possible to differentiate in this model
which of these is the greatest influence. The likelihood
of contaminants in the medium is low in those incubations
without FCS where an entirely artificial defined chemical
medium was used and where bacterial growth was reduced to
undetectable levels by the addition of antibiotics. I
conclude that one of the first two mechanisms is therefore
more probable.
The term "CRP production" is used to here to indicate
the amount of CRP in the medium at the end of the
incubation period, and does not allow for newly
synthesised CRP not released from hepatocytes or the small
amount of pre-existing stored CRP which was released into
the medium. However after 24 hours incubation the
intracellular CRP concentration was similar to the levels
measured in the fresh liver samples, so that the amount of
CRP in the medium eguates well with the amount of newly
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synthesised CRP. This is illustrated for two of the
experiments in the figures 19 and 20 on pages 127 and 128.
The sensitivity of the ELISA used to measure CRP was
0.1 mcg/1. The actual concentration of CRP in the media
varied between 0.23 and >1000 mcg/1. Values close to the
lower limit of the assay were fairly common in phase 1,
thus justifying initial fears and the decision to continue
incubation for 24 hours. However in phase 2 CRP
concentrations in the medium were much greater and a
shorter incubation time of say 12 hours which would have
reduced the deterioration of the liver slices, would still
have produced easily measurable quantities of CRP.
The influence of adding interleukin-1 to the medium
Despite the production of CRP in the 'unstimulated'
samples a clear effect of the additional stimulation of
exogenous IL-1 was seen both in phase 1 and phase 2. CRP
production (that is CRP released into the medium) rose
from a median of 7.48 to 11.85 mcg/mg liver in phase 1,
and from 93.3 to 137 mcg/mg liver in phase 2, and both of
these differences were highly statistically significant
(figures 13 and 14, pages 117 and 118).
That the concentration of 10 U/ml IL-1 added was
sufficient to produce maximal CRP production is supported
by the dose response curves obtained from liver samples in
14 patients. These showed no extra production of CRP when
20 U/ml IL-1 was added to the medium when compared to 10
U/ml. Indeed 5 U/ml induced the synthesis of nearly as
much CRP as 10 U/ml (median 161 mcg/mg liver v 192 mcg/mg)
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and the difference was not statistically significant. This
finding is supported by the work of Le and Mortensen using
mouse hepatocyte cultures who noted that the addition of
excess concentrations of IL-1 reduced the synthesis of
acute phase proteins [Le and Mortensen, 1986].
The effect of increasing the oxygenation of the sample
The effect of changing the concentration of oxygen in
which the slices were incubated was guite marked, raising
median CRP production some 13 fold from 10.8 to 137 mcg/mg
liver (figure 16, page 122). In retrospect this ought to
have been carried out from the beginning.
The concentration of oxygen selected for the
prolonged preservation of tissue varies with differing
tissues. True organ culture, ie. the maintenance of stable
functioning solid blocks of tissue, of mammalian liver has
not yet been achieved though maintenance of histologically
normal liver for up to 6 days has been reported [Campbell
and Hales, 1971]. The optimal oxygen concentration appears
to be between 60% [Laufs and Walker, 1970] and 95%
[Campbell and Hales, 1971]. Concentrations as high as 3
atmospheres have been used but these proved toxic [ibid].
The effect of foetal calf serum (FCS) in the medium
Figure 22, page 131, presents some data which is
difficult to interpret. It appears to show that in the
absence of FCS in the incubating medium, IL-1 has no
stimulating effect on CRP production. FCS in itself did
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not affect the level of CRP synthesis, but the two
together had a significant effect greater than neither or
either one alone.
These findings appear to suggest that the FCS was
necessary for IL-1 to exert its effect. One explanation
might be that IL-1 did indeed require to be cleaved to a
smaller fragment to become biologically active in this
model, analogous to its action in muscle proteolysis. As
has been stated in the introduction the smaller fragment
of 4.3 kD was dubbed proteolysis inducing factor
[Dinarello et al, 1984]. Whether cleavage is also
necessary for liver stimulation and whether FCS contains
the necessary proteolytic enzymes to achieve this are
questions that would merit further study. I am not aware
of any evidence in the literature that cleavage is
required for actions other than muscle proteolysis.
Alternatively, FCS may contain a factor or factors
that facilitate protein synthesis and allow IL-1 to act.
The levels of CRP production in the 'unstimulated' liver
slices show that there was in fact considerable
stimulation of the acute phase in these slices too and
this was not enhanced by the presence of FCS. However if
these slices were stimulated by cytokines released from
Kuppfer cells in the specimen, IL-1 might not be the
active cytokine responsible.
Reproducibility
The greatest problem in drawing conclusions from the
results of this arm of the study is the lack of
- 167 -
reproducibility which was observed. Although there was
quite good reproducibility between pairs of liver slices
processed under identical conditions on the same day from
the same patient, there was little concordance between
samples from different patients on different days under
otherwise apparently identical conditins of incubation.
Figure 23 on page 139 shows a correlation between the
values for CRP production from 26 paired samples of liver
from the same patients. The correlation is close with an
Rs value of 0.968. However as can be seen from the graph
on page 131 the range of values for CRP production under
apparently identical conditions is wide, the largest being
approximately 100 times greater than the least. Although
differences might have arisen from the ability of the
liver of different subjects to produce CRP, these were not
reflected in such wide variations in plasma levels seen in
the in vivo results. The composition of the medium, the
gas phase and other aspects of the incubation were well
controlled with little if any variation.
The greatest area of variability in the entire process
from biopsy to completion was the handling of the liver
between its removal from the patient and being placed into
the incubator and in particular the slicing process.
Differences in traumatic damage by handling and slicing
and variations in the thickness of the slices are likely
to have influenced the extent and speed of tissue necrosis
which occurred during the incubation period which in turn
are likely to have been the major determinant of
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variability in CRP production. The deficiencies in the use
of the Mcllwain tissue slicer have been described above.
Although when selecting slices for incubation the greatest
variability in slice thickness could be avoided by naked
eye appearance small differences in slice thickness would
make a large difference to the distance that nutrients and
oxygen would have to diffuse to reach the innermost cells.
Consecutive slices from the same piece of liver tended to
be similar in thickness accounting for the consistent
results in multiple incubations from the same patient, but
variations in the size shape and connective tissue content
of different biopsies affected the slice thickness despite




In conclusion this study has investigated the
relationship between nutritional status and the magnitude
of the acute phase plasma protein response by experiments
in vivo and in vitro.
The experiments in vivo have demonstrated that
patients undergoing surgery for upper gastrointestinal
cancer exhibit a typical acute phase reaction but have not
been able to demonstrate an influence of the nutritional
status of the patients on the magnitude of the acute phase
response observed.
In the in vitro experiments a method of incubating
human liver slices has been developed and this has been
used to demonstrate and measure the synthesis of CRP by
human liver tissue. Interleukin-1 has been shown to
stimulate the synthesis of CRP by the liver slices.
This arm of the study has also failed to demonstrate
a relationship between the nutritional status of the
patient from whom the liver sample was taken and the
amount of CRP synthesised by the liver sample.
The failure to find a relationship between
nutritional status and the acute phase response may have
been because malnutrition of the degree seen in these
patients is not an influence on the acute phase plasma
protein response, the response being preserved because of
its central role in repair and recovery after injury, or
because the methods employed have not been suitable to
demonstrate such an effect. They may have failed to allow
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for other influences on the magnitude of the acute phase
response or have not had the power to demonstrate it.
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5. SUGGESTIONS FOR FURTHER STUDY
I believe that the question of the influence of
nutrition on the acute phase reaction has not yet been
definitively answered by this study or by previous work.
In the in vivo part of this study the number of patients
studied is insufficient to be certain that the result is a
genuine one. With the slight but definite trends seen by
the Milan and Glasgow groups I think it is likely that an
effect of nutrition will be demonstrated if a large enough
study is undertaken which would overcome the influence of
the other variables affecting the magnitude of the acute
phase response as discussed earlier. The methodology used
in all of these studies including this one is simple and
no significant changes require to be made.
The influence of nutritional status on the capacity
of liver to synthesise acute phase proteins is still
unanswered. I think that the model chosen for this study
does offer a suitable means for studying the problem but
that more attention has to be paid to achieving greater
preservation of the liver tissue and greater
reproducibility before a consistent result is likely to
emerge. The main areas for improvement are the handling
and slicing of the liver prior to incubation and the
method of maintaining oxygenation and the supply of
nutrients to the liver tissue during the incubation. In
addition now that we know that the amount of protein
synthesised is sufficiently great that the sensitivity of
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the ELISA is not a problem, a shorter period of incubation
should be chosen, probably between 12 and 20 hours.
Attempts should be made to obtain a tissue slicer
along the lines of that described by Krumdieck, which
seems to have significant advantages over the Mcllwain
machine and with which good results have been described.
Adopting a dynamic organ culture system in which the
liver slice and its medium are kept in constant motion
would also appear to offer advantages in preservation of
the hepatic architecture. Mixing of the medium in this way
would maintain the liver in contact with nutrient rich
medium and wash away secreted products in a more
controlled manner to free diffusion. It also maintains the
liver in contact with the medium on both surfaces. In the
roller method the liver is placed on the inside of a mesh
within a tube and agitated by rollers. Gassing is
maintained by way of a gas permeable membrane in the cap
of the tube.
These methods could be developed and tested on liver
from patients undergoing routine upper abdominal surgery
which is freely available, reserving the patients to be
studied (the malnourished cancer bearing group) until the

















































3: COMPOSITION OF DULBECCO'S MODIFIED EAGLE MEDIUM
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Phenol red 1 5
Sodium pyruvate 110
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Plate 1. Photomicrograph of liver from patient no 17
stained with PAS. Appearances of fresh liver prior to
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Plate 2. Photomicrograph of liver from patient no 17
stained with PAS. Appearances after incubation for two
hours. For description see page 136.
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Plate 3. Photomicrograph of liver from patient no 17
stained with H & E. Appearances after incubation for four
hours. For description see page 136.
Plate 4. Photomicrograph of liver from patient no 17
stained with H & E. Appearances after incubation for six
hours. For description see page 137.
- 229 -
«K'
* .*•*" ■ -1
- * »
> • •








, I . *
t V - . ' • • J»• V »*
' * •
„ • . - ** J* 4- »
•
. ••• • •;
; '# '■ * . *. • * ./ • • _ *.














' -' : *
•\ •' •;■ ■
Plate 5. Photomicrograph of liver from patient no 17
stained with H & E. Appearances after incubation for 24
hours. For description see page 137.
Plate 6. Photomicrograph of liver from patient no 28
stained with H & E. Appearances before incubation. For
description see page 137.
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Plate 7. Photomicrograph of liver from patient no 28
stained with H & E. Appearances of fresh liver prior to
incubation. For description see page 137.
Plate 8. Photomicrograph of liver from patient no 28
stained with H & E. Appearances after incubation for 18
hours. For description see page 138.
- 231 -
Plate 9. Photomicrograph of liver from patient no 28
stained with H & E. Appearances of edge of specimen after
incubation for 24 hours. For description see page 134.
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Plate 10. Photomicrograph of liver from patient no 28
stained with H & E. Appearances of periportal area after
incubation for 24 hours. For description see page 134.
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